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Longitudinal studies, where data on study subjects are collected over time, is increasingly
involving multivariate longitudinal responses. Frequently, the heterogeneity observed in
a multivariate longitudinal response can be attributed to underlying unobserved disease
states in addition to any between-subject differences. We propose modeling such disease
states using a hidden Markov model (HMM) approach and expand upon previous work,
which incorporated random effects into HMMs for the analysis of univariate longitudinal
data, to the setting of a multivariate longitudinal response. Multivariate longitudinal data
are modeled jointly using separate but correlated random effects between longitudinal
responses of mixed data types in addition to a shared underlying hidden process. We use
a computationally efficient Bayesian approach via Markov chain Monte Carlo (MCMC) to
fit such models. We apply this methodology to bivariate longitudinal response data from
a smoking cessation clinical trial. Under these models, we examine how to incorporate a
treatment effect on the disease states, as well as develop methods to classify observations
by disease state and to attempt to understand patient dropout. Simulation studies were
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Analysis of Longitudinal Data
1.1 Longitudinal Data in Clinical Studies
In the past 50 years, there has been an explosion in the number of clinical studies evaluat-
ing the efficacy or effectiveness of medical interventions, or examining the natural history
of a multitude of diseases. In some studies, the intervention or duration of illness may be
relatively short, requiring very few observations on each subject, recorded cross-sectionally
over a short time period. However, in most studies, the course of treatment or duration of
disease are long enough to measure some aspects of the disease, or response to treatment
over a period of time on each subject. When such repeated measurements are collected
over a period of time, the data are said to be longitudinal.
1.2 Analysis Approaches
The benefits of using longitudinal over cross-sectional data, including the ability to measure
change over time, are numerous and well-documented (Diggle et al., 2002). However,
the correlation between observations of the same subject often complicates the analysis
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of longitudinal data. Independence of observations is a ubiquitous assumption used in
the majority of statistical analysis, and while usually suitable in cross-sectional analyses,
the repeated nature of the observations within a subject in longitudinal studies makes
it quite likely that observations within each subject are correlated. How to account for
this within-subject correlation has resulted in several different approaches to the analysis
of longitudinal data. Each differs slightly in the underlying assumptions, and resulting
interpretation, but are usually aimed at: describing the change of the response variable
over time, estimating the effect of any explanatory variables, and often characterizing the
variability of the response attributable to a subject and/or the nature of the correlation
within a subject between the repeated observations.
With these aims in mind, let Yit be the response variable for subject i = 1, 2, . . . , N
at time t = 1, 2, . . . , ni, where each subject i has ni repeated measurements. Let xit be p
dimensional vector of explanatory variables (possibly time-varying) for subject i at time t.
Three general classes of analysis approaches have been described in the literature (Diggle
et al., 2002), which address the aims of longitudinal data analysis in different ways. A
brief overview of the approaches follows.
1.2.1 Marginal models
Marginal models are one such approach to the analysis of correlated data in general, and
have been used extensively in longitudinal data analysis. This marginal approach focuses
primarily on modelling the marginal expectation of the response, E(Yit), as a function
of the explanatory variables. This marginal expectation of Yit is modelled to depend on
the explanatory variables through a known link function, such that if E(Yit) = µit, then
g(µit) = x
′
itβ, where g is known as a link function.
Similarly, the marginal variance of Yit, V ar(Yit) = v(µit)φ, is assumed to depend only
on a function of the marginal mean of Yit and a scale parameter, φ. Lastly, the correlation
between Yit and Yit′ is assumed to be a function of the marginal means, and perhaps some
2
additional parameters, α, such that Corr(Yit, Yit′ ) = ρ(µit, µit′ ,α).
Under this approach which specifies the marginal mean and variance of Yit in addition
to its correlation structure of the response variable within each subject, a generalized









V −1i (yi − µi) = 0 (1.1)
where Vi is often referred to as the working covariance matrix of Yi, which depends on
both β and α. The solution of 1.1 is solved iteratively. Given initial estimates for β,
α and φ, updates of β can be solved by 1.1, which can then be used to update α and
φ, and repeated until convergence. Several methods have been discussed in the literature
on how to do the latter update of α, but this iterative process will yield estimates of
β which are as efficient (asymptotically) as estimates when α is known. Further work
has yielded methods where estimation of α and β is done through separate estimating
equations (Prentice, 1988; Zhao and Prentice, 1990).
1.2.2 Mixed effects models
Mixed effects models introduce random effects which are unobservable variables which cap-
ture some aspects of the heterogeneity observed among subjects (Laird and Ware (1982)).
The central assumption of mixed effects models is that conditional on these random ef-
fects, (bi), the longitudinal responses, Yit, are independent, though this assumption can be
relaxed to include situations where Yit|bi and Yit′ |bi, t 6= t
′
are correlated. Furthermore,
we assume that these random effects are mutually independent, and arise from a common
(possibly multivariate) distribution, and are independent of any explanatory variables.
We take a similar initial approach to that of marginal models, where if Yit is from an












where xit and wit are p and q dimensional vectors of explanatory variables.
In specific circumstances, the random effects can be viewed as nuisance parameters, and
conditional likelihood methods are available, but are not appropriate when subject-specific
effects are of interest. In contrast, the marginal distribution of the response variable can
be obtained by integrating out the random effects of the joint distribution of Yi and bi,









where Θ is the combined parameters of β and Σ where the latter is the covariance matrix
of the random effects. If yit are Gaussian, and the random effects are assumed to arise
from a (possibly multivariate) Gaussian distribution (Laird and Ware, 1982), then 1.2 has
a closed-form solution, and estimation of Θ is relatively straightforward. On the other
hand, in most other circumstances, 1.2 has no closed-form solution, and the integration
must be evaluated numerically.
1.2.3 Transition models
Transition models are another method used to model longitudinal data. Transition models
focus on modeling the response, yit, conditional on the subjects history, denotedHit, where
for subject i Hit = {yik, k = 1, 2, . . . , t − 1}. Such models are often modeled as a q-order
Markov chain, where the conditional distribution of yit depends only on the most previous
q responses for subject i, {yit−1, yit−2, . . . , yit−q}. An example of a transition model for a
first-order Markov chain is presented in Figure 1.1, where the current observation Yit is
only dependent on the most previous observation.
Even under the Markov assumption, except in special cases, it is usually not possible to
specify the full likelihood directly, and instead, the conditional likelihood is usually used:
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Yi1 Yi2 Yi3 Yi4 · · ·
Figure 1.1: Simple first-order Markov chain transition model for subjects i. Yit represents







Focus of such models has often been on binary Markov chains, where, for example, a
first-order Markov chain for a binary response can be modeled as:





where here β represents a vector of fixed effects, and α represents any interaction between
the the previous response, yit−1, and one or more of the covariates. Using 1.3 we can
fully specify a transition matrix for a binary Markov chain, such that for any subject with
covariate values xit, we have a transition matrix of the form:p00 p01
p10 p11
 ,













Even when fitting higher order Markov models, fitting such models can be done us-
ing ordinary logistic regression, provided that the transition events are uncorrelated. If
there is heterogeneity between individuals in terms of the transition probabilities, then an
appropriate model may be for example:






where bi is a subject-specific random effect as presented in section 1.2.2, where bi ∼
N(0, σ2bi). In this case the heterogeneity between subjects is modeled through the introduc-
tion of random effects, and subsequently makes the transition within a person correlated.
Marginal methods have also been used in this setting to account for the within-subject
correlation (e.g., Azzalini (1994)).
1.3 Joint or Multivariate Responses in Longitudinal
Data Analysis
Thus far, we have only examined the longitudinal models for one response variable. In
many circumstances, more than one response variable is followed longitudinally, and
analysing both jointly may be beneficial. Until recently, methods for multiple longitudinal
outcomes have largely been based on simple approaches where each outcome is analyzed
separately, or by reducing the dimension of the multiple outcomes through a factor anal-
ysis or principal components type of approach. The former approach is reasonably easy
to implement, with the approaches already discussed, but ignores both the correlation
between longitudinal outcomes and/or other features such as measurement error likely to
exist in one or more of the outcomes. Reducing the dimension of the multiple outcomes
is also easy to implement, and can quite often capture much of the correlation between
outcomes. In such models, inference is focused on the principal components, and not the
original outcome variables, often affecting interpretation of the model results and can also
be difficult to implement in situations where the longitudinal data are unbalanced, or when
the outcomes are measured at different time points.
Modelling multivariate responses can be difficult. If the joint distribution of the two
or more responses is known, then inference is relatively straightforward. Such a circum-
stance would allow for inference to be conducted marginally, as well as jointly. In general,
the joint distribution of two or more longitudinal responses is rarely known, and can be
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difficult to obtain for data arising from different data types (e.g. continuous and discrete).
Furthermore, inference is complicated in situations when outcomes are measured at differ-
ent time points and/or are unbalanced.
Several modeling approaches have been developed which jointly model the longitudi-
nal responses by specifying in a number of different ways the joint distribution of the
longitudinal responses (e.g., Chapter 13-16, Fitzmaurice et al. (2006)). One possibility is
the use of a conditional model, where the joint likelihood of the two or more responses is
factorized. For two longitudinal responses, the factorization would typically look like:
f(y1, y2) = f(y1|y2)f(y2) = f(y2|y1)f(y1)
where y1 and y2 are vectors of two different longitudinal responses. Marginal inference is
often difficult, as the parametric form may not be the same for the marginal and conditional
models. Additionally, specification of the factorization can be very complicated in the
setting of more than two responses.
Another frequently used method of modelling multivariate longitudinal responses is
the introduction of latent variables which often simplify the joint distribution by assuming
conditional independence. In a simple scenario, two responses, Y1 and Y2 are said to be









The conditional independence assumption, f(y1, y2|b) = f(y1|b)f(y2|b) is central to many
different multivariate longitudinal models.
These shared random effects can be introduced into both models for Y1 and Y2, for
example that for each subject:
Y1t = β1 + b+ β2t+ ε1t
Y2t = β3 + γb+ β4t+ ε2t
(1.7)
7
where in this example, ε1t
iid∼ N(0, σ21), ε2t
iid∼ N(0, σ22) and b ∼ N(0, σ2b ). The parameter γ
is used to scale the random effects and define the dependence between responses. In this


























Another frequently used method is to again introduce random effects, but instead of shar-
ing the random effect across the longitudinal responses, use separate, but correlated ran-
dom effects in the longitudinal responses (e.g., Gueorguieva and Agresti (2001)). The
conditional independence assumption noted in 1.6 still applies, but 1.7 becomes:
Y1t = β1 + b1 + β2t+ ε1t
Y2t = β3 + b2 + β4t+ ε2t
(1.9)
where in this example, ε1t
iid∼ N(0, σ21), ε2t
iid∼ N(0, σ22) and (b1, b2)
′ ∼ MVN(0,Σ). Here,
(b1, b2) is multivariate normal, with a covariance matrix, Σ, which allows for the random
effects, b1 and b2 to be correlated.
The correlation within and between responses is similar to 1.8 but, the correlation
between responses is now:










In these latter two settings, examples of which are described in 1.7 and 1.9, extensions
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to responses of different types (e.g. both continuous and discrete responses), and exten-
sions to more than two response variables are relatively straightforward. Furthermore, the
conditional independence assumption under most circumstances makes the interpretations
of model parameters the same marginally as they would be jointly. In the shared random
effect case, the correlation between responses is only dependent on the correlation within
responses, whereas in the separate random effects case, the correlation structure between
responses is attenuated by the use of separate random effects, and is therefore not depen-
dent solely on the within-response correlation of each response.
In both the shared and separate random effects cases, the conditional independence
assumption stated in 1.6 requires integration to compute the full joint distribution of the
response variables. As was the case in the simple, univariate response setting discussed in
section 1.2.2, there are settings when integrating out the random effects results in a closed-
form solution, but it is often the case that numerical integration is required. When the
number of longitudinal response variables is relatively small, the numerical integration can
often be accomplished without too much trouble, but as the number of responses increases,
the dimension of the integral increases, often making computation difficult. To get around
this computational difficulty, some have advocated modelling all pairs of response vari-
ables, and subsequently using a pseudo-likelihood approach (Fieuws and Verbeke, 2006).
We have presented several analysis approaches which allow for modeling of multivariate
longitudinal data by introduction of latent variables, which can model both between- and
within- variable correlation. However, using a latent variable approach is not the only
way to model such data, and others (e.g., Gray and Brookmeyer (1998, 2000)) have used
marginal approaches to model more than one longitudinal response.
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1.4 Extensions to Mixed Effects and Transition Mod-
els
As can be seen from the discussion above, there exists many different approaches to the
modeling of longitudinal data. In particular, the features of mixed effects often allow for
investigation of subject-specific longitudinal responses and has also immediate extensions
to multivariate longitudinal data, while transition models are often useful in situations
where values for previous response(s) predict a future response. As can be seen in 1.5,
random effects can be easily introduced into transition models for binary responses, allow-
ing for subject-specific transition probabilities. We will be using this idea to incorporate
a latent or hidden transition model which governs two or more observed longitudinal re-
sponses which are also modeled using separate, but correlated random effects as discussed
in 1.9. These types of models will be used to model data arising from a longitudinal
smoking cessation study described in Chapter 2, where heterogeneity can be attributed to
between-subject differences, but also dynamic changes in disease state.
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Chapter 2
Smoking Cessation Clinical Trials
and the Naltrexone Augmentation
Study
2.1 Smoking Cessation Studies
The inhalation of tobacco smoke poses many public health concerns, including the devel-
opment of cancer and cardiovascular disease. In the United States, tobacco smoking (from
herein referred to as simply smoking) is the leading preventable cause of death in adults.
Though the medical community has recommended for some time that chronic smokers quit
smoking tobacco, the prevalence of smoking on adults has exceeded 20% in most devel-
oped countries. This is primarily due to the addictive nature of one of tobacco’s principle
ingredients, nicotine (Benowitz, 1996).
Since becoming a major public health concern in the latter half of the 20th-century,
clinical trials examining the efficacy and/or effectiveness of both behavioral and phar-
maceutical interventions for smoking cessation have been conducted. For pharmaceutical
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interventions, there have been many randomized clinical trials where one or more phar-
maceutical agents are administered and compared amongst themselves and/or a control
group.
One class of these agents is known as nicotine replacement therapies (NRT), which
reduces nicotine withdrawal by replacing the nicotine consumed through smoking most
often transdermally by patch or orally via a gum. Several investigations have attempted
to augment NRT by co-administration with other agents, and have reported cessation
rates higher than patch alone (Stead et al., 2008). Despite the development of such inter-
ventions, many individuals fail to quit smoking over the smoking cessation study period.
Smoking within the first few weeks has been shown to be a strong predictor of failure to
quit smoking during the remainder of the study (Kenford et al., 1994).
2.1.1 Study outcomes
In most such trials, the protocols are structured for a relatively short period of frequent
(e.g., once per week) follow-up for several weeks, sometimes followed by period of less
frequent (once every several months) longer term follow-up, the latter often done after
treatment has been terminated as per the study design. Evaluations of treatment efficacy
are often focused on the short period of frequent follow-up, and most studies investigat-
ing the efficacy of pharmaceuticals evaluate smoking abstinence as their primary study
outcome.
The definition of smoking abstinence is often complicated, and can vary between stud-
ies. Smoking abstinence is usually monitored longitudinally over the study period through
one or more measures of smoking status. These measures may be biochemical or self-
reported.
These longitudinal measurements along with the duration and/or timing of smoking
abstinence are often reduced to a single binary study outcome of smoking abstinence.
Often these definitions are very strict, requiring abstinence throughout the entire study
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period on all outcomes, or complete abstinence after some predetermined time (often one to
two weeks post baseline). Additionally, missing data are often handled in a strict manner,
where patients who dropout of the study for any reason are assumed to have smoked.
2.1.2 Measurements of smoking status
While typically reduced into a single binary study outcome, smoking status is often mon-
itored longitudinally by one or more types of methods. Such methods can be classified as
patient reported or biochemical.
Patient reported: self-reported smoking counts
Patient reported smoking counts are commonly collected in many settings, to describe
smoking cessation, as well as the effect of smoking exposure on health outcomes. Patients
most often record a total number of cigarettes smoked over a well-defined time period (a
day or week). These are often recorded in a diary, and are often subject to well-described
epidemiological biases, and have been shown to generally underreport the prevalence and
amount smoked (Patrick et al., 1994). Self-reported counts are usually whole numbers,
and are often relatively consistent day-to-day within a patient. These counts are often
near notable fractions or numbers of packs (e.g. 1 pack is 20 cigarettes, it is common to
see common fractions of 20 cigarettes (10 - half a pack, 30 = 1.5 packs, etc)) (Wang and
Heitjan, 2008). Since, as previously mentioned, self-reported smoking counts are generally
believed to represent underreporting of the number of cigarettes smoked, smoking status
is usually defined by any smoking reported during some defined time period.
Biochemical: carbon monoxide
Biochemical monitoring is often done through detection of carbon monoxide through oral
respiration, where the subject exhales into an instrument which estimates the concentration
of carbon monoxide (CO) in parts per million (ppm). Smoking status is usually determined
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by a pre-defined threshold, where exceeding this threshold is used to provide evidence
that the participant smoked. Commonly used thresholds are 8 or 10 ppm. While CO is
often found in small quantities in humans due to other exposures to CO, smokers have
significantly higher levels of CO during periods when they have smoked. A limitation of
using CO in smoking cessation studies is due to its relatively short half-life (5-6 hours),
meaning that a CO assessment on a Tuesday would likely fail to detect the presence of
a smoking event even a few days prior, on Friday or Saturday for instance. Further, any
non-smoking related environmental exposure to CO in close time proximity to the study
visit may be detected and falsely interpreted as evidence of smoking.
Biochemical: serum cotinine
Serum cotinine is another biochemical marker of smoking, which detects a metabolite of
nicotine within the blood. It is considered a sensitive and specific method to detect smoking
status, as nicotine exposure is not common in the environment in the absence of tobacco
products. Serum cotinine is often considered the gold standard for measuring smoking
status, since it has a longer half life in plasma than is typical for CO, and has generally
been found to have higher sensitivity and specificity to detect smoking when compare CO
(Jarvis et al., 1987). With that said, confirming smoking status is a difficult task, and
would require 24 hour video surveillance, or something similar to achieve 100% certainty of
an individual’s status at a given time. Further, in smoking cessation studies, it is common
to use NRT via gum or patch for at least a portion of the study, and unfortunately, serum
cotinine has limited utility as a determinant of smoking status during any period which
permits NRT. In addition, obtaining serum cotinine requires blood work, which may be
considered burdensome to many potential study participants.
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2.1.3 Assuming dropouts as treatment failure
As is the case in many clinical studies, subject dropout is common in smoking cessation
studies. It is a very frequent assumption to consider these individuals as treatment failures
(i.e., smokers) when determining smoking status, regardless of the reason for dropout. This
is usually considered to be a conservative assumption, which we do not believe in some
situations is justified, and will be discussed in more detail in section 5.3 in this thesis.
2.2 The Naltrexone Augmentation of Nicotine Patch
Study
O’Malley et al. (2007) conducted a study similar to those described in section 2.1, where
naltrexone augmentation of NRT was evaluated for smoking cessation. At baseline all
subjects enrolled in the study received NRT, and were randomized in a double-blind fashion
to receive placebo, or one of three levels of naltrexone (25, 50 and 100 mg) in a roughly
1:1:1:1 allocation. Subjects were followed six weeks with weekly study visits, where CO
was measured and self-reported smoking count journals were collected. At the conclusion
of the six weeks, the study drugs were discontinued, and follow-up visits were scheduled
at 3, 6 and 12 months. O’Malley et al. (2007) used a composite definition of smoking
abstinence, which used both self-reported and CO to define smoking status, and examined
smoking abstinence over several time periods. Continuous abstinence was defined as no
self-reported smoking from baseline to week 6, and all weekly assessments of CO below
the study’s 10 ppm CO threshold, and prolonged abstinence was defined similarly, but
allowed a grace period from baseline to the second study visit, where smoking information
recorded in that period was ignored.
In total, 673 subjects underwent screening, with 400 proceeding to randomization.
Of these 400, 385 received therapy, with 295 completing the six weeks of therapy. It is
15






































Figure 2.1: Agreement between self-reported (SR) smoking count (any during a given
week), and having a positive CO test for that week for several CO thresholds
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noteworthy that 354 of the 385 receiving therapy had some sort of evaluable (≥ 1 week)
follow-up as it pertains to both CO and self-reported smoking counts. The analysis that
follows primarily focuses on these 354 subjects. Abstinence rates varied depending on
the definition and duration of abstinence, as well the treatment subgroup, with 41-52%
achieving prolonged abstinence and 39-52% maintaining continuous abstinence. Although,
the authors note a possible treatment effect in the group with the highest dose of naltrexone
when compared to placebo in the treatment completers, naltrexone was not observed
to have any statistically significant treatment effect at any other dose or definition of
abstinence. A possible beneficial effect on weight was also noticed for some subjects taking
naltrexone.
Using the data from this study (O’Malley et al., 2007), we examined the agreement
between the self-reported and CO determinants of smoking status across several different
thresholds of CO. In Figure 2.1, smoking status as determined by self-report (SR) is defined
as self-reported smoking of any cigarettes during the week, and the agreement with the
CO-determined smoking status is investigated across several CO thresholds. As can be
seen in this figure, the agreement between the two measurements is highest for the higher
thresholds of CO, as would be expected, however, the maximum level of agreement is
approximately 80%, and does not appear to depend on the visit week. Similarly in Figure
2.2, a higher level of SR smoking status (> 5 cigarettes on any day of the week specified)
results in a generally higher level of agreement between the SR definition and the different
CO thresholds, with the maximum agreement approximately 90-95% for the higher CO
thresholds.
In Figure 2.3, we can see the effect of the short half-life for CO. Each set of boxplots
represents one study week, with the right most boxes in each plot representing the days
closet to the CO measurement (i.e. day 7 is the day of the CO measurement, and day 6
would be the day before, etc). Day 0 represents individuals who did not report smoking
during the week. A stark increase in both the variability and median is noted on the
17
most right hand side of these plots, illustrating the limited period of sensitive detection of
smoking through CO.






































Figure 2.2: Agreement between SR smoking count (more than 5 total cigarettes reported
in the week), and having a positive CO test for that week for several CO thresholds (in
ppm)
We can also assess the agreement between measures, by treating one as a gold standard,
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Figure 2.3: The effect of last day of recorded self-reported smoking by study week on end
of week CO reading (in ppm).
Note: Day 0 represents no self-reported smoking during the specified study week, and day
7 would be the day of the CO measurement.
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CO as Predictor 

























Figure 2.4: ROC plots for Prediction of each of the measure of assessing smoking status.
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and assessing the prediction of the other measure by receiver operator characteristic (ROC)
curves. These curves for each of the SR and CO measures are presented in Figure 2.4,
where we see that the predictive power for one is relatively strong, but not perfect.
2.3 Statistical Methods of Smoking Cessation Data
In most efficacy studies of smoking cessation the primary analyses focus on comparing
the proportion of those subjects who achieved and/or maintained abstinence over some
pre-determined time period among the treatment groups. These analyses can be typically
accomplished through relatively simple methods, but given the complex nature of the lon-
gitudinal data, some methodological literature has been dedicated to smoking cessation
studies. Some of the most relevant literature is described below.
In Borrelli et al. (2002), the issue of study participant dropout is examined in smok-
ing cessation studies. As discussed briefly in section 2.1.3, the definition for abstinence
often assumes that those individuals who dropout of the study prior to the completion of
the treatment period are deemed non-abstainers (i.e., they have smoked). Borrelli fits a
multinomial logistic regression model examining the characteristics of three groups: the
quitters (abstainers), the smokers, and the dropouts. They reported that dropouts differ
from smokers in several ways, but most notably, that individuals who believe the therapy
works (self-efficacy) were more likely to dropout when compared to smokers, while there
was no difference in terms of self-efficacy of smokers and quitters. They also report that
the rate of dropout may differ among treatments, and treating dropouts as smokers may
miss important features that treating them separately would capture.
Qin et al. (2009) reports on modelling two binary smoking observations (i.e., two obser-
vation time points where smoking was observed or not) by using two latent class models.
The joint model of both observation time points conditional on latent class membership
was assumed to be conditionally independent of the dropout of the second observation.
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This model is then compared to other methods (shared parameter model and weighted
GEE) for handling the missing data due to dropout, and found to perform generally bet-
ter.
Liu, Daniels and Marcus (2009) reports of jointly modeling a binary longitudinal re-
sponse and a continuous response variable in the context of a smoking cessation trial. The
focus of their analysis is on a binary longitudinal response (smoking status) and a contin-
uous longitudinal response (body weight). They use a probit form of the binary process
which involves an underlying latent variable which simplifies modeling the two responses
as multivariate normal data. Particular attention is paid to the association between smok-
ing status and body weight, in which case it is noted that the treatment weakens the
association between smoking and weight gain.
2.4 Overview and Motivation
As we have described, smoking cessation studies generate longitudinal data in which data
are collected in order to define smoking status. This is a very blunt way of summarizing
what can be problematic measures of smoking status. Despite this, the dichotomizing
of individuals into groups of smoking status, and often ignoring that individuals may be
transitioning between smoking statuses is a common way to treat these data, both in the
medical and statistical literature. Furthermore, two separate groups may not fully describe
the nature of the treatment effect in such studies. This concern is described in more detail
in section 3.3.4.
There is a need to describe the longitudinal data from smoking cessation studies in a
much more efficient manner which allows for investigating change over time and in general,
more effective use of the longitudinal data generated from such studies. With this in mind
we will explore how to use the measurements used to define smoking status as a multivariate
longitudinal response, that is governed by a hidden process which could closely resemble
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smoking status. In Chapter 3, we will describe a modeling framework to accomplish this,
where the heterogeneity in a multivariate longitudinal response attributable to between-
subject differences in addition to heterogeneity arising from changes in disease state can
be effectively modeled. In Chapter 4, we will discuss the benefits of utilizing multivariate
approaches for these models, when compared to the univariate alternatives. We will also
attempt to assess the utility and meaning of the hidden states to determine if they resemble
some meaningful state that a patient may encounter in a smoking cessation study. In
Chapter 5, we will describe methodologies for predicting hidden states, and we will also
examine how this hidden process approach may be used to handle missing data and dropout
which can be problematic in studies such as smoking cessation. In the last chapter, we





Analysis with Mixed Effects Hidden
Markov Models
3.1 Introduction
Longitudinal studies, where data on study subjects are collected over time, is increasingly
involving multivariate longitudinal data where multiple responses are collected repeat-
edly over the study period. Approaches to the analysis of multivariate longitudinal data
have included marginal (e.g., Xu and MacKenzie (2012)) and conditional models (e.g.,
Gueorguieva and Agresti (2001)). Other procedures generally aim to simplify the depen-
dence between responses and therefore often reduce the computational burden involved
in conducting inference in such models (e.g., Fieuws and Verbeke (2006)) or reducing the
dimension of the longitudinal response (e.g., Scott, James and Sugar (2005)). The ad-
vantages of using multivariate longitudinal data are well documented and include a more
complete use of the data collected and the ability to estimate and utilize the dependence
between longitudinal responses, among others.
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While these collected multivariate responses may generally correlate with some mean-
ingful clinical endpoint, they may be inadequate in capturing the relevant endpoint and
the study intervention’s effect on this endpoint. For example, in studies of addiction, the
relevant clinical endpoint is often the relapse or abstinence rates, which are conceptually
understood, but are not effectively measurable. Estimation of these rates is usually done
by attempting to determine the underlying disease states at each study visit via thresholds
of often several measures of abstinence through biochemical or self-reported data. Both
classes of measures used to estimate the disease states are limited by their sensitivity and
specificity due to the potential for misclassification and measurement error.
This type of scenario is quite common in clinical trials, where an underlying or hidden
disease state is modelled via one or more surrogate endpoints or biomarkers, most often by
establishing thresholds of one or more of these responses to define the hidden disease states.
For example, as discussed in Chapter 2, O’Malley et al. (2007) conducted a clinical trial
evaluating a drug’s efficacy for smoking cessation and collected two surrogate endpoints
which had thresholds to define a disease state and the true outcome of interest, smoking
abstinence. This approach often ignores: any unexplained heterogeneity in the responses
by, for example, measurement error or between-subject heterogeneity, the dependence
structure of the responses, and any information pertaining to the subject’s response or
disease state history.
Instead of defining thresholds or cutoffs to define disease states, it may be more efficient
to model the data as generated from these hidden or latent disease states. Latent class
models have successfully been used for multivariate longitudinal data (e.g., Proust-Lima
et al. (2009)), but are generally limited by their static latent states. Recently, hidden
Markov models (HMMs) have been used in the context of longitudinal studies (Altman,
2007; DeSantis and Bandyopadhyay, 2011; Maruotti and Ryden, 2009; Scott, James and
Sugar, 2005; Shirley et al., 2010). Scott, James and Sugar (2005) developed a model for
multivariate continuous longitudinal data by reducing the dimension of the response, and
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modelling the reduced response as a HMM. Dimensional reduction can be challenging
in a general setting, where responses may be of different data types (e.g., binary and
continuous). Alternatively, Altman (2007) develops a general framework for using HMMs
to model univariate longitudinal data by introducing random effects into both the observed
response and hidden state components of the HMM. This work has subsequently been used
by others (DeSantis and Bandyopadhyay, 2011; Maruotti, 2011; Shirley et al., 2010).
Using the general framework described by Altman (2007), we extend her work to
the setting of multivariate longitudinal data. This is done by modelling the observed
longitudinal responses jointly through separate, but correlated, random effects, and a
common hidden Markov process. We apply this type of analysis to data generated from a
smoking cessation clinical trial examining the efficacy of a pharmacological intervention.
In this paper we briefly review previous work done with mixed effects hidden Markov
models (MHMMs) and extend this to the setting of multivariate longitudinal data in
section 3.2. In section 3.3 we justify and outline a Bayesian procedure for computing esti-
mates of such models using Markov chain Monte Carlo (MCMC). In sections 3.4 and 3.5,
respectively, we perform a simulation study to understand the properties of the estimates
generated from such models in a variety of situations, as well as perform an analysis from
a motivating smoking cessation clinical trial example. In section 3.6 we will discuss the
results of our models, simulations and possible limitations and extensions.
3.2 Mixed effects hidden Markov models for multi-
variate longitudinal responses
In this section we will describe a general framework for using mixed effects hidden Markov
models (MHMMs) to describe longitudinal data. HMMs are characterized by two depen-
dent processes. The first being a hidden process, which is usually assumed to adhere to
the Markov assumption. The second, the observed process, which, when conditioned on
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Zi1 Zi2 Zi3 · · ·
Yi1 Yi2 Yi3 · · ·
bi
Figure 3.1: Mixed Effects Hidden Markov Model structure for subject i, with hidden
process Zi, observed process Yi, and random effects, bi
the current value of the hidden process, is independent of any future or past value of the
hidden or observed processes (see Figure 1). HMMs have a great number of applications
(Zucchini and MacDonald, 2009), and as mentioned in the introduction, have recently been
applied to the analysis of longitudinal data (Altman, 2007; DeSantis and Bandyopadhyay,
2011; Maruotti and Ryden, 2009; Scott, James and Sugar, 2005; Shirley et al., 2010).
3.2.1 Model Framework
Let Zit denote the hidden process for subject i, (i = 1, 2, . . . , N) at some common time
points t, (t = 1, 2, . . . , ni). Further, denote Zi to comprise all values of Zit for subject i, and
Z to be all values of Zi for all i. Assume Zit arises from an M−state Markov chain with
transition matrix P and initial probability vector, π. This paper will primarily focus on
HMMs arising from first-order time homogeneous Markov chain hidden processes, where
P (Zit = k|Zi,t−1 = j) = pjk for all t > 1, and P (Zi1 = k) = πk, where j, k = 1, . . . ,M .
Let yit denote a R−dimensional multivariate longitudinal response for subject i at time
t, such that yit = [yi1t, yi2t, . . . , yiRt]
′
. Similar to above, let yi denote all the observations
27
for subject i across all longitudinal responses and time points, and y be the collection of
all yi for i = 1, 2, . . . , N .
Suppose that the joint longitudinal responses arise from an HMM such that Yit and
Yit′ were independent given the HMM’s current state, Zit and Zit′ , respectively, for t 6= t
′
.
Further assume that there exists an additional set of i.i.d subject-specific random effects,
bi, where conditional on the current hidden states, Zit, and random effects, bi, each yirt is
independent (see Figure 1) with a distribution, frk(yirt|zit = k), in the exponential family
with canonical parameter, θirtk, and link function hr(.), where:







Here τr represents the fixed effect intercept term for each hidden state, as defined through
an M -dimensional hidden state vector, Hirtk, which defines some contrast dependent on
Zit. Typically, we will define Hirtk such that for hidden state k, H
′
irtkτr is the cumulative
sum of the first k elements of τr (see page 36 for more details). Further, xirt is a vector
of covariates at time t for subject i when Zit = k for the r
th longitudinal response, and
the associated fixed effect coefficient parameters for these covariates are represented by
βrk, which also could vary over different values of the hidden process. Finally, wirtk is the
row vector of the model matrix for the random effect for the rth longitudinal response for
subject i at time t while in hidden state k.
When R = 1, i.e., the longitudinal response is univariate, this is one of the models
proposed by Altman (2007) where she outlines a procedure to do maximum likelihood









by Gauss-Hermite quadrature, where Θ comprises of all parameters of the MHMM, includ-
ing parameters associated with the hidden process, P and π, parameters associated with
the canonical link of the observed processes in (3.1), β and τ , parameters associated with
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the random effects, Σ, and additional parameters associated with the observed process,
unrelated to (3.1), ξ. Here αini is a quantity often referred to as the forward probabilities
(Baum et al., 1970) for subject i, and defined for t = 1 as αi1 = πG(yi11), where,
G(yi1t) = diag[f11(yi1t|zit = 1, bi,Θ), f12(yi1t|zit = 2, bi,Θ), . . . , f1M(yi1t|zit = M, bi,Θ)],
for any t > 0 and recursively for t = 2, 3, . . . , ni, as αit = αi,t−1PG(yi1t).
Extending this structure for R > 1 involves only modifying G(yi1t), and using the




fr1(yirt|zit = 1, bi,Θ),
R∏
r=1
fr2(yirt|zit = 2, bi,Θ),
. . . ,
R∏
r=1
frM(yirt|zit = M, bi,Θ)],
for t > 0.
A common scenario involving R > 1 would be to have separate but correlated random
effects for each distinct longitudinal response. Under the scenario of a single random
intercept in each response, wirtk would simply be a vector of all zeroes, except the r
th
entry which would be one. Alternatively, a shared random effect across responses could
also be used, and is accommodated by this parameterization, but the focus of this paper
will be on the case of separate, but correlated random effects. To evaluate L(Θ;y) under
these situations becomes increasingly difficult as R increases, as each evaluation often
involves the computation of N R− (or more) dimensional integrals, most often with no
closed-form solutions. Although better numerical approximations to the integral may be
possible, the integrand is not a relatively simple function of bi due to the inclusion of
the hidden process. Nonetheless, we have been able to fit such models when R = 2 by
a Gauss-Hermite quadrature approximation, but we have found in general as R increases
there is a need for computationally sophisticated methods to fit these models. We will
therefore focus the attention of this paper to other methods for computing such models.
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3.2.2 Motivating Example
A motivating example arises from a pharmacotherapy smoking cessation study, where
smokers were randomized to one of three active treatment groups or a placebo, with
all participants receiving nicotine replacement therapy (O’Malley et al., 2007). After
randomization, subjects were followed for six weeks, with longitudinal follow-up occurring
weekly. At each study visit, patients self-reported daily cigarette use over the previous
week, and a carbon monoxide (CO) test was administered as physiological monitoring of
cigarette intake.
In this example, we will be modelling a bivariate longitudinal response consisting of a
count, Yi1t, of the number self-reported days out of nit in t
th week where subject i reported
to smoke at least one cigarette, and Yi2t which consists of the transformed (log[Y + 1]) CO
level at the tth week’s study visit. Under the framework outlined in section 2, we model
these data as follows:
















This is only one form of how this complex multivariate longitudinal data could be described.
It has been hypothesized (Hughes et al., 2003; Killeen, 2011) that smoking cessation in-
terventions are described by a three state Markov model with a state space of: regular
use, withdrawal and long term abstinence. While these states are generally understood,
determining the state of a given subject at a given time remains difficult, as self-reported
smoking (Yi1t) is known to generally underreport both the prevalence and intensity of
smoking (Patrick et al., 1994), and the higher CO levels (Yi2t) observed when smoking
have a limited half-life where they are detectable (perhaps as little as 4-6 hours). Further,
in most analyses of these types of data, thresholds of one or more of these longitudinal re-
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sponses define a binary status (smoker/non-smoker) ignoring the intermediate withdrawal
state. Under the models described in this section, we will examine the properties of both
the hidden and observed processes.
3.3 Bayesian Inference
Although it is possible to use maximum likelihood estimation by approximating (3.2) by
numerical integration, it, in general, remains difficult to apply such methods to the frame-
work discussed in section 3.2.1 when the dimension of the longitudinal response exceeds
two, or in many other common scenarios. Indeed, when examining more complicated
random effect structures for a single dimensional longitudinal response under a MHMM,
Altman (2007) relies primarily on stochastic integration to fit such models. While it may
be possible to continue with this approach as R or the number of random effects increase,
we have generally found the Bayesian approach to be more efficient from a computational
perspective, as well as relatively easy to adapt to many other more complicated situations
and models.
3.3.1 Prior Specification
Specifying a prior for Θ is largely dependent on the specific circumstances for the target
of inference. It is often convenient for sampling to choose independent conjugate priors
for each component of Θ. In other circumstances the choice of prior may often depend on
the distributional assumptions of each dimension of the longitudinal response, the chosen
link function, (3.1), or other requirements such as subject-expert knowledge, if available.
In general, it is often convenient to factor [Θ] as:
[Θ, b] = [β, τ ,P ,π, b,Σ, ξ] = [β, τ ]× [P ]× [π]× [b|Σ]× [Σ]× [ξ] . (3.3)
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While there may be certain circumstances where it is merited to use the joint prior of ξ
(such as when two or more responses are normally distributed conditional on their random
effects and hidden states), it is often useful to factorize each component of [ξ] as
∏R
r=1[ξr].
Once the priors have been specified, sampling from the posterior distribution, [Θ|y], can
be done through Gibbs sampling (Geman and Geman, 1984) or similar approaches. If
one could sample the hidden states, z, at each iteration of the Gibbs sampler, one could
then sample each component of Θ, conditional on the current simulated value of the other
parameters, y, and the hidden states, z. After this is completed, the hidden states, z,
must be updated, which will be discussed just below in section 3.3.2. This procedure is
then repeated until stationarity is reached, effectively sampling from the posterior, [Θ|y].
3.3.2 Updating the Hidden States
Taking a Gibbs sampling approach for sampling from the posterior involves alternating
between sampling from [Z|y,Θ, b], and [Θ, b|y, z]. Sampling from the latter is relatively
straightforward, and there are many possible approaches to this which are discussed in
section 3.3.3. On the other hand, updating the hidden states has been well studied in the
Bayesian context using MCMC methods, and Scott (2002) examines two different updating
schemes in the setting of HMMs. The preferred option involves sampling from [Zi|y,Θ]
through a stochastic recursion (Scott, 2002) outlined below, instead of sampling
[Zit|y,Θ, bi, . . . , Zi,t−2, Zi,t−1, Zi,t+1, Zi,t+2, . . .] separately. This method, while more com-
putationally intensive, has been found to mix better in some situations (Cappe, Moulines
and Ryden, 2005; Scott, 2002), and considering the addition of another hidden component
to our models, mainly bi, improving mixing even at the expense of reasonably efficient
computation is a desired attribute.
This update procedure involves computation of forward probabilities discussed in sec-
tion 2.1. Each sequence of hidden states Zi1, Zi2, . . . , Zini can be done separately for each
i. In general, αit(j) = P (Zit = j,yi1, . . . ,yit|bi,Θ), where αit(j) is the jth element of αit.
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Calculating αit is done recursively, and is a function of only Θ, bi and y. For t = ni, we
note that αini(j) = P (Zini = j,yi|bi,Θ) ∝ P (Zini = j|yi, bi,Θ). Therefore, sampling Zini
can be done by calculating αini(j) for each hidden state j, and then normalizing by dividing
by their sum over j,
∑M
j=1 αini(j). Sampling the remaining ni−1 hidden states for subject
i can be reduced to sampling from [Zit|yi, bi,Θ, Zi,t+1, . . . , Zini ] for t = ni−1, ni−2, . . . , 1.
This is done by using an argument originating from Chib (1996), and described in details
by Zucchini and MacDonald (2009) and adapted to the situation we encounter such that:
P (Zit|yi, bi,Θ, Zi,t+1, . . . , Zini) ∝
P (Zit|yi1, . . . ,yit, bi,Θ)P (yi,t+1, . . . ,yini , Zi,ni+1, . . . , Zini |yi1, . . . ,yit, Zit, bi,Θ) ∝
P (Zit|yi1, . . . ,yit, bi,Θ)P (Zi,t+1|Zit, bi,Θ)×
P (yi,t+1, . . . ,yini , Zi,ni+2, . . . , Zini |yi1, . . . ,yit, Zit, Zt+1, bi,Θ) ∝
P (Zit|yi1, . . . ,yit, bi,Θ)P (yi,t+1, . . . ,yini , Zi,ni+2, . . . , Zini |Zt+1, bi,Θ)P (Zi,t+1|Zit, bi,Θ) ∝
P (Zit,yi1, . . . ,yit|bi,Θ)P (Zi,t+1|Zit, bi,Θ).
The last line is familiar, as both of the quantities in the product have been described
previously, where P (Zit = j,yi1, . . . ,yit|bi,Θ) = αit(j), and P (Zi,t+1 = k|Zit = j, bi,Θ) =
pjk from the transition probability matrix, P . Hence, after Zini has been sampled, the
remainder of the hidden states can be sampled in reverse order (t = ni−1, ni−2, . . . , 1) by
computing P (Zit = j|yi, bi,Θ, Zi,t+1 = k) ∝ [αit(j)]pjk for j = 1, . . . ,M , and normalizing
each by their sum over all j. This process can be repeated for each i separately, and once
updated, sampling from the other components of the posterior can be conducted.
3.3.3 Sampling from the Posterior
Under the prior structure discussed in section 3.3.1, we can take a Gibbs sampling ap-
proach, where groups of parameters with priors in conjugate families are sampled from
directly. With all other variables, alternative methods can be used such as adaptive rejec-
tion sampling (Gilks and Wild, 1992), or Metropolis within Gibbs sampling (Smith and
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Roberts, 1993). Given the current values of Θ and b, section 3.3.2 discusses how to sample
from [Z|y,Θ, b]. This is generally one of the most computationally intensive steps.
Under the MHMM assumptions, and applying the form of (3.3), we can get relatively
simple forms of the posterior distributions: [P |Θ−P ,y, z, b] = [P |z], [π|Θ−π,y, z, b] =
[π|z], and [Σ|Θ−Σ,y, z, b] = [Σ|b], where the notation [A|B−A] is used to represent the
conditional distribution of A given all elements in B except A. If conjugate priors are
chosen for P , π, and Σ as we have done below, this often involves directly sampling from
Dirichlet and inverse Wishart distributions (discussed further below).
The full conditional distributions of the other sets of parameters, β, τ , b, ξ will generally
depend on some or all of the other parameters, in addition to the observed data, y and
current simulated hidden states, z. We have found it convenient to sample from the
βr and τr separately for each r. Under this approach, [βr, τr|y, z, b, ξr] ∝ [βr, τr] ×∏N
i=1
∏ni





r=1 frk(yirt|bi,β, τ , ξr, zit = k). Lastly, sampling from [ξ|.] will largely be
application specific, but will not generally depend on P or π.
Sampling from the Posterior for the Motivating Example
Sampling from the posterior for the example in section 3.2.2 is relatively straightforward.
As above, we will initially choose a relatively uninformative Dirichlet conjugate prior





[1, 1, 1] for π(s) and the uth row of P , respectively, and in this setting we will assume
that bi
iid∼ MVN(0,Σ). We also chose a conjugate inverse Wishart(ν0,Ψ0) prior for Σ,
with ν0 = 1 and let Ψ0 be the 2 × 2 identity matrix. Lastly, we chose a flat prior for
β and τ , such that [β, τ ] ∝ 1. In this example, there is also one extra parameter for
r = 2, where ξ21 =
1
σ2ε
, which will also come from a conjugate family, Gamma(a0, b0), with
a0 = 0.001, b0 = 0.0002.
Once Zi is updated for each i as outlined in section 3.3.2, the following can be sampled
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from the full conditional distributions:































[π(s)|z] ∼ Dirichlet(ζ(s)π + q(s)),




t=1 1(zi1 = m, vi = s),
[P (s)u |z] ∼ Dirichlet(ζ(s)u + q(s)u ), where P (s)u is the uth row of P (s),






1(zit = m, zi,t−1 = u, vi = s),










































































× (P + c) matrix(c being the length of xi2t)


















































































We use a random walk Metropolis within Gibbs steps to sample from the full condi-
tionals of [bi|.] and [βr, τr|.] for r = 1 separately, where r = 2 has a multivariate normal
full conditional distribution which can be sampled from directly. The interpretation of τr
depends on the defined model matrix, Hirt common to all i and t, but not necessarily r
(although we will not examine this here). For instance, the contrasts suggested by Scott
(2002) are similar to the following: H
′
irt1 = [1, 0, 0], H
′
irt2 = [1, 1, 0], and H
′
irt3 = [1, 1, 1]
for Zit = 1, 2 and 3, respectively, and we will use these throughout the remainder of the
paper. To perform sampling for the two steps which require Metropolis within Gibbs sam-
pling, a multivariate normal proposal distribution is used, and updated during a burn-in
period. Approximately 1.5 million iterations are used, and thinned to 50,000 samples.
Trace plots, density estimates, and auto-correlation plots as an assessment of stationarity
and mixing are presented in section 3.7.
3.3.4 Introducing a Treatment Effect for the Hidden Process
Thus far we have only discussed the situation where covariates are introduced to the pa-
rameters associated with the observed component of the MHMM. While this may be useful
in many situations, often the desired treatment contrast may manifest itself through some
function of the transition probabilities. Indeed, in situations where y are surrogate end-
points or biomarkers, defining a treatment effect (via β in (3.1)) in terms of observed
longitudinal responses may be difficult depending on the treatment’s effect on: the un-
derlying hidden process, the observed longitudinal responses, or the relationship between
these observed and hidden responses. In situations where the hidden states resemble the
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underlying true disease outcomes, as they often can, it may be more advantageous to think
about the treatment’s effect on the hidden states.
With the above said, we can define simple treatment effects for a finite number of
categorical time-invariant covariates by defining a subject-specific transition matrix, Pi =∑S
s=1 1(vi = s)P
(s), where vi is a variable indicating treatment group membership, and
P (s) is the transition matrix for the sth treatment group. Similarly, a treatment effect
can be defined in terms of the initial probabilities, where πi =
∑S
s=1 1(vi = s)π
(s), where
π(s) are the initial probabilities for treatment group s. Often, the HMM is assumed
to be stationary, and/or the initial probability vector is considered a vector of nuisance
parameters, but there may be circumstances where this quantity has a particular meaning.
This scenario is probably most interesting in the setting of a randomized clinical trial
where the hidden states of the study subjects may be considered very homogeneous at
baseline. For instance, at enrollment in the motivating example, all subjects were required
to be current smokers, so in principle the initial probability vector has a very specific
interpretation – being that it is the first week’s transition probability from hidden state
three (the highest smoking state), or something conceptually similar.
Given a large enough sample size in each stratum with a reasonably high frequency
of transitions between states within each strata, it is possible to add as many treatment
groups as needed. Other methods would be required to sample from the posterior in cases
where the desired covariate of interest was non-categorical.
In our motivating example from section 3.2.2, we will examine four different scenarios
involving different ways to look at the treatment effect within the hidden process. Scenarios
include:
I) No treatment effect, where Pi = P and πi = π (common) for all i,
II) Treatment effect in only the initial state probabilities (π(0) and π(1)), with common
transition matrix, P (0) = P (1) = P ,
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III) Treatment effect in only the transition probabilities (P (0) and P (1)), with common
initial state probabilities, π(0) = π(1) = π, and
IV) Treatment effect in both the initial state probabilities (π(0) and π(1)), and the tran-
sition probabilities (P (0) and P (1)).
3.3.5 Label Switching
A well known phenomenon in using MCMC approaches to mixture models including HMMs
is that of label switching. This phenomenon generally occurs because of the invariance of
the likelihood under any relabeling of the mixture components. Several approaches have
been proposed to alleviate this problem, including putting identifiability constraints on the
parameter space, and decision theoretic approaches (Stephens, 2000). Under a MHMM,
we have found label switching to occur only under certain situations. As we shall see,
in our motivating example the modes of most components of the observed multivariate
longitudinal responses are well separated by the hidden states, and we do not generally
observe label switching. This is consistent with an observation noted by Scott, James and
Sugar (2005), who also used Bayesian methodology to examine a HMM with a longitudinal
response, but without between-subject heterogeneity in the observed response; they did
not observe label switching in their study either. Scott, James and Sugar (2005) attributes
this mainly to the increased dimensionality of the observed longitudinal response.
In other settings, we do find label switching to occur, most often when the modes are less
well-separated, and the between-subject heterogeneity is high. When this occurs, after the
sampling is completed, and as is frequently done, we relabel the states by ordering one of
the observed response population means. In the examples examined in this paper we have
a bivariate observed longitudinal response, and generally we have not found that choosing
one response’s parameters over the other to significantly effect the results. Generally,
the ordering of the response’s parameters disagreed at a relatively low frequency (<1%),
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and we picked the continuous response (r = 2) on which to reorder the labels. In other
situations, such as when the dimension of the longitudinal responses increase, this may no
longer be the case, and other strategies may be required.
3.4 Simulation Study
A simulation study was conducted to assess the properties of the estimators derived from
the modeling framework and MCMC sampling methods described above and to assess ro-
bustness in a few situations of possible concern. Data were simulated for a model similar
to those described in the example discussed in section 3.2.2, where the hidden process, z,
and the random effects, b, are first sampled independently (unless stated otherwise), and
given these data, the observed multivariate longitudinal response, y is simulated. Patients
are randomly allocated in a 3:1 (265:89) manner to treatment and placebo, which have
identical population level models with the exception of their respective transition proba-
bility matrices (scenario III in section 3.3.4). As is the case in the motivating example,
the observed process is sampled at six time points (ni = 6 for all i). For the purposes
of this simulation study, data are assumed to not be missing, and 200 simulations from
each situation will be fit using the methodology described in section 3.3.3. The following
situations were examined:
1. The data are generated from a MHMM with well-separated modes (τ1 = [−5, 3, 3],
τ2 = [1.2, 0.2, 1.1]) with a large between-subject heterogeneity in the binomial re-
sponse via independent multivariate normal random effects. The random effects
are i.i.d and have a covariance matrix Σ = [ 8.5 0.50.5 0.1 ] with the inverse of the resid-
ual error, 1
σ2ε
, in the normally distributed response set at 10.0. The hidden process
is generated from a common initial probability vector, π = [0.6, 0.25, 0.15], and















2. The data are generated from a MHMM with less well-separated modes (τ1 = [−3, 1.5, 1.5],
τ2 = [1.2, 0.5, 0.5]) with a smaller between-subject heterogeneity in the binomial re-
sponse via independent multivariate normal random effects. The random effects are
again i.i.d multivariate normal and have a covariance matrix Σ = [ 5.0 0.50.5 0.1 ]. The other
sets of parameters, P (0), P (1), π, and 1
σ2ε
remain the same as situation (1).
3. The data are generated similar to situation (2), but the distribution of the random
effects, bi, are dependent on the initial hidden response, Zi1. For the subjects in
hidden state 1 at time t = 1, the random effects are generated from a mean zero
multivariate normal distribution with covariance matrix, Σ1 = [ 4.5 0.50.5 0.1 ]. Conversely,
in those subjects in hidden states 2 or 3 at t = 1, the random effects are generated
from a mean zero multivariate T distribution with 8 degrees of freedom, and covari-
ance matrix, Σ2 = [ 5.5 0.50.5 0.1 ]. As in situation (2), with the exception of τ the rest of
the parameters remain set at the same values as is situation (1).
Situation (1) closely describes the motivating example, where the modes of the hid-
den states are well-separated, and there is a great deal of heterogeneity in the binomial
response. As can be seen in Table 3.1, the estimates generated from sampling from the
posterior, π(Θ|y), are generally well-behaved, and the posterior means are generally close
to the true parameter values, while the posterior standard deviations are generally close to
the standard deviation of the posterior means over the simulations. With the exception of
Σ22, the 0.025 and 0.975 posterior quantiles cover the true parameter value very close to
95% of the time, with overall mean coverage (all parameters) of 94.7%. In the exception
(Σ22), the reduced coverage may be due in part to the bias introduced by our prior.
Situation (2) generally resembles situation (1), but the population modes are less well-
separated. As would be expected, for the relevant parameters (τ ,P ,π) the average pos-
terior standard deviations have generally increased with the increased level of uncertainty
pertaining to the hidden states. Additionally, some significant bias can be observed, in
particular for p021 and p
0
32 the bias is quite large. In both of these parameters (and most
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π1 0.60 0.5961 0.0437 0.0436 0.960
π2 0.25 0.2555 0.0423 0.0440 0.955
p012 0.10 0.1075 0.0391 0.0385 0.955
p013 0.05 0.0534 0.0175 0.0178 0.950
p021 0.60 0.5601 0.1115 0.0993 0.955
p023 0.20 0.2033 0.0735 0.0681 0.960
p031 0.10 0.1134 0.0445 0.0440 0.935
p032 0.10 0.1135 0.0466 0.0452 0.960
p112 0.10 0.1042 0.0237 0.0245 0.945
p113 0.05 0.0510 0.0101 0.0093 0.975
p121 0.60 0.5935 0.0631 0.0580 0.960
p123 0.20 0.1976 0.0387 0.0383 0.945
p131 0.10 0.1043 0.0366 0.0356 0.960
p132 0.30 0.3070 0.0455 0.0454 0.955
τ11 -5.00 -4.9905 0.2292 0.2374 0.945
τ12 3.00 2.9859 0.1755 0.1772 0.925
τ13 3.00 3.0311 0.2162 0.2262 0.940
τ21 1.20 1.2028 0.0217 0.0236 0.940
τ22 0.20 0.1983 0.0384 0.0424 0.940
τ23 1.10 1.0987 0.0362 0.0381 0.930
Σ11 8.50 8.5833 0.9981 1.0238 0.955
Σ12 0.50 0.5100 0.0760 0.0648 0.985
Σ22 0.10 0.1092 0.0103 0.0108 0.855
1
σ2ε
10.00 10.0868 0.3916 0.3939 0.945
where πk is the initial probability of hidden state k, p
s
jk is the j, k transition probability for
the sth treatment group for the hidden states, τrk is the intercept term for response r and
hidden state k, Σ is the covariance matrix of the random effects, and σ2ε is the residual
error associated with response 2.
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others), the bias is in the direction towards the prior mean, which is 1/3 for p021 and p
0
32.
Indeed, the posterior for these parameters in many, but not all, of these simulated instances
is very flat, and much of the information appears to come from the prior. It should be
noted however, that both p021 and p
0
32 are parameters associated with the placebo group,
which has a reduced sample size when compared to the treatment group. In the corre-
sponding treatment group parameters, p121 and p
1
32, while we still observe some bias, it
is considerably less than that observed in the smaller placebo group. This is probably
not too surprising, given that based on a sample size of 89 and six time points, the true
expected frequency of some of these hidden state transitions are as few as 9. Some caution
is therefore merited when using these models when the frequency of such transitions may
be low, but can be effectively monitored from the Zit samples collected during the MCMC
algorithm. In cases where the row totals of the transition frequencies are low, or have high
variance, this may be a situation where significant bias may occur. In such cases, it may
be necessary to reduce the hidden state space, so that the transition frequencies are high
enough, or alternatively incorporate more information into the prior. With this in mind,
we repeated this simulation with a more informative prior, such that the hyperparameters,
ζ
(s)
u , for the transitions probabilities, are [8,1,1], [6,2,2] and [1,1,8] for the first, second and
third rows of P (s), respectively, which we use across both sets of parameters associated
with the placebo and treatment groups (i.e., for both s = 0 and 1). This analysis is also
presented in Table 2 and is denoted ”situation (4)”, and generally reduces any bias ob-
served in the problematic parameters. In spite of the noted bias in many of the transition
probabilities noted in Table 2 for situation (2), it is noteworthy that the coverage proba-
bilities of the 95% quantile range are generally well behaved, albeit many of these intervals
are very wide.
As can be seen in Table 3, in situation (3) we encounter many of the same problems
noted in situation (2). Generally, the parameter estimates are not any more biased than






























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































π1 0.60 0.5683 0.0802 0.0761 0.950
π2 0.25 0.2716 0.0751 0.0588 0.985
p012 0.10 0.1403 0.0879 0.0737 0.960
p013 0.05 0.0619 0.0296 0.0247 0.980
p021 0.60 0.4926 0.1586 0.1413 0.945
p023 0.20 0.1970 0.1138 0.0847 0.985
p031 0.10 0.1258 0.0671 0.0613 0.980
p032 0.10 0.1609 0.0995 0.0721 0.985
p112 0.10 0.1296 0.0643 0.0545 0.965
p113 0.05 0.0558 0.0191 0.0173 0.955
p121 0.60 0.5652 0.1119 0.0884 0.975
p123 0.20 0.1810 0.0713 0.0565 0.970
p131 0.10 0.1089 0.0538 0.0410 0.990
p132 0.30 0.3163 0.0884 0.0728 0.985
τ11 -3.00 -3.0422 0.1740 0.1758 0.930
τ12 1.50 1.4147 0.2792 0.2725 0.940
τ13 1.50 1.5726 0.2875 0.2587 0.965
τ21 1.20 1.1990 0.0323 0.0300 0.970
τ22 0.50 0.4575 0.0956 0.0970 0.920
τ23 0.50 0.5482 0.0941 0.1644 0.920
Σ11 - 5.8255 0.6166 0.6550 -
Σ12 - 0.6190 0.0772 0.0992 -
Σ22 - 0.1370 0.0147 0.0209 -
1
σ2ε
10.00 10.0380 0.5644 0.5286 0.970
where πk is the initial probability of hidden state k, p
s
jk is the j, k transition probability for
the sth treatment group for the hidden states, τrk is the intercept term for response r and
hidden state k, Σ is the covariance matrix of the random effects, and σ2ε is the residual
error associated with response 2. S.D. - standard deviation
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also resolve the biases observed in this situation. Since this situation is a departure from a
modeling assumption (the independence of bi and Zi), it is particularly reassuring to note
that the parameters associated with the observed process have very small bias, and the
95% quantile coverage probabilities are generally well-behaved. Further, we may expect
this departure to also bias the estimates of πk, but this is not any more severe than
what was observed in situation (2). We would expect a similar reduction of the bias in
this situation, as was observed when a more informative prior is used on the transition
probability matrix, P as was seen when contrasting situations (2) and (4) in Table 2.
We performed an additional three simulation situations to better understand the bias
observed in situations (2) and (3). The following situations were examined:
(5) The data are generated from a MHMM with well-separated modes (τ1 = [−3, 1.5, 1.5],
τ2 = [1.2, 0.5, 0.5]) with a large between-subject heterogeneity in the binomial response
via independent multivariate normal random effects. The random effects are i.i.d and




the normally distributed response set at 10.0. The hidden process is generated from a














(6) Identical to (5) in all respects except the number of observation times is doubled for
each patient, such that ni = 12 for all i.
(7) Identical to (5) except, τ1 = [−5, 3, 3] and τ2 = [1.2, 0.1, 1.10].
The results from these three additional simulations are presented in Tables 3.4 and 3.5.
In each case, the default Dirichlet distribution prior with hyperparameters [1, 1, 1] is used
for π(0), π(1), and the rows of each of P (0) and P (1), which was a case we encountered some
significant bias in our estimates in situations (2) and (3). Situation (5) resembles situation
(2) most closely, but has reduced between-subject heterogeneity (Σ11) on the binomial
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response. While the bias does appear to slightly decrease for both p021 and p
0
32, the major
difference is noted when comparing the results to situation (6), where the number of
observation times have been doubled, resulting in a quite dramatic decrease in bias. This
is reassuring that given a large enough sample size, the bias is virtually non-existent where
in other similar situations, it had been significant.
Lastly, situation (7) preserves the random effects covariance structure and hidden state
transition probability matrices while increasing the separation of the observed modes in
each of the responses by the hidden states, such that we can compare it directly to situation
(5). We note significantly less bias in this situation when compared to situation (5) for
parameters like p021 and p
0
32, as well as situation (1), which has the same population modes,
but larger between-subject heterogeneity in the observed response.
Throughout situations (1) to (7) we note consistent bias in the parameter Σ22, often
with lower than expected coverage obtained by the 95% posterior distribution quantiles.
This is likely due to the prior choice for Σ22 which has a mean which is approximately
ten times higher than its true value. We anticipate with a better choice in prior, that this
bias and low coverage would be reduced, if not eliminated, but this illustrates a possible
sensitivity to prior specification, and some care should be taken when choosing a prior
distribution for this and other parameters, especially when the relevant sample size is
relatively small for the specific parameter (e.g., p021).
3.5 Results from the smoking cessation motivating
example
In section 3.2.2 we described a motivating example from a smoking cessation clinical trial
(O’Malley et al., 2007) examining a pharmacological intervention’s effect on the rates
of maintained smoking abstinence over six weeks. When introducing methods to model













































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































π1 0.60 0.5894 0.0472 0.0473 0.955
π2 0.25 0.2600 0.0457 0.0461 0.950
p012 0.10 0.1161 0.0423 0.0423 0.935
p013 0.05 0.0521 0.0170 0.0175 0.940
p021 0.60 0.5670 0.1073 0.0979 0.955
p023 0.20 0.2095 0.0712 0.0692 0.955
p031 0.10 0.1081 0.0433 0.0399 0.970
p032 0.10 0.1192 0.0457 0.0424 0.945
p112 0.10 0.1090 0.0273 0.0289 0.945
p113 0.05 0.0517 0.0100 0.0104 0.940
p121 0.60 0.5956 0.0609 0.0594 0.965
p123 0.20 0.1960 0.0376 0.0365 0.960
p131 0.10 0.1007 0.0375 0.0341 0.955
p132 0.30 0.3051 0.0453 0.0393 0.970
τ11 -5.00 -5.0249 0.2266 0.2293 0.970
τ12 3.00 2.9754 0.1938 0.1845 0.965
τ13 3.00 3.0420 0.1798 0.1682 0.965
τ21 1.20 1.2014 0.0213 0.0209 0.965
τ22 0.10 0.1926 0.0374 0.0365 0.960
τ23 1.10 1.1014 0.0353 0.0380 0.940
Σ11 2.00 2.0139 0.2700 0.2692 0.930
Σ12 0.35 0.3436 0.0422 0.0424 0.960
Σ22 0.10 0.1069 0.0098 0.0091 0.915
1
σ2ε
10.00 10.0168 0.3755 0.3771 0.950
where πk is the initial probability of hidden state k, p
s
jk is the j, k transition probability for
the sth treatment group for the hidden states, τrk is the intercept term for response r and
hidden state k, Σ is the covariance matrix of the random effects, and σ2ε is the residual
error associated with response 2. S.D. - standard deviation
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treatment effects for the hidden states. We fit each of these models as outlined in section
3.3 with a varying number of parameters (18-26 parameters), and present the results in
Table 3.6.
We generally note very little effect of treatment with the exception of perhaps a differ-
ence between p032 and p
1
32. This quantity represents the transition probability of individuals
transition from the smoking state to the intermediate withdrawal state. Ideally, this would
be high, suggesting the readiness of individuals to stop smoking, even if they had restarted
during the study period. Surprisingly however, the rate is higher in the placebo group,
suggesting that those on treatment actually do worse than those on placebo. From our
MCMC samples, we can estimate quantities like, P (p132 > p
0
32), which is estimated as
0.072 in model III and 0.067 in model IV. This provides some evidence that the treat-
ment may inhibit abstinence in those subjects who remained or returned to smoking after
the first week of the study period. Without formally performing model selection or hy-
pothesis testing on the two different treatment effects, this single effect remains somewhat
unconvincing.
Using model I, we can estimate the transformed means of the CO levels for each of the
hidden states by using τ2 and the chosen structure of Hirtk. In our case, Hirtk corresponds
to the cumulative sum of the elements of τ2, resulting in estimates of the means of 1.18,
1.53 and 2.63 for the first, second and third hidden states, respectively. By inverting the
log(Y + 1) transformation, the estimates on the untransformed scale are 2.26, 3.63 and
12.95, for hidden states one, two and three, respectively. In most studies a CO threshold
of 8 or sometimes 10 ppm is used as evidence that a subject is smoking, suggesting our
results provide some face validity. Similarly, for the daily self-reported binomial response,
an individual with this response’s corresponding random effect equal to zero would have
an estimated probability of smoking on a single day of 0.005, 0.22 and 0.66 for the first,





















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Overall, we have outlined a general framework for modeling multivariate longitudinal data
in the setting where heterogeneity in the longitudinal responses is explained by random
subject-specific differences or heterogeneity introduced from a given subject transitioning
through multiple disease states. We believe this could have a great number of applications
in the modeling of longitudinal data arising from the study of addiction, where the underly-
ing disease states are conceptually understood to contribute significantly to the underlying
heterogeneity of measured responses, but ultimately are difficult to measure directly. Mod-
eling a multivariate longitudinal response through a MHMM has a degree of flexibility in
accounting for the correlation and heterogeneity between- and within-responses by the
incorporation of the hidden process along with the random effects, that is not present
by using only one of these components in isolation. Others have applied HMMs to the
setting of addiction (DeSantis and Bandyopadhyay, 2011; Shirley et al., 2010), as well as
other diseases where a similar argument can be made pertaining to the underlying dis-
ease states, such as multiple sclerosis (Altman, 2007) and schizophrenia (Scott, James and
Sugar, 2005). While the development of these methods are in their infancy, we believe
they can play an important role in understanding how a treatment works on true clinical
outcomes through understanding how a treatment may affect the modeled hidden states.
Further, these types of models may help to better plan future clinical studies, by, for
example, providing better estimates of sample size requirements (Altman, 2012).
The methods as presented in this paper have several limitations which can be addressed
in future work. First, in univariate responses, Altman (2007) allows for between-subject
heterogeneity in the hidden state process in addition to the observed process. We have
not considered this case, mainly due to the limited number of observation times (six) in
the motivating smoking cessation study. Scott, James and Sugar (2005) take a Bayesian
approach allowing for subject-specific transition matrices under a hierarchal model, and
we believe a similar approach could be adapted to models presented in this paper, if
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the dataset permitted it. In other situations, such as when there is a large number of
observation times, a small hidden state space, little between-subject heterogeneity or well-
separated modes in the observed process, or specific types of hidden process transition
probability matrices, it may be possible to consider the inclusion of random effects in the
hidden process. As we saw during the simulation study in situation (2), one must be
aware of the limitations of such models, when so many forms of heterogeneity are being
accounted for simultaneously. If a homogeneous common transition matrix cannot be
applied to a specific dataset, it may be more worthwhile looking at somewhat simpler
alternatives like increasing the order of the hidden process, which may be more feasible
than using subject-specific transition matrices in certain situations.
Secondly, we were limited in our ability to perform formal hypothesis testing, or other
model selection techniques. Bayes factors and their analogues are usually the basis of
Bayesian hypothesis testing, but are generally reliant upon estimating the integrated like-
lihood of the models in question. The generally poor convergence of estimators such as the
harmonic mean commonly used to estimate the integrated likelihood, along with the com-
plex nature of our likelihood, make hypothesis testing reliant on the integrated likelihood
difficult. Others have proposed information criteria, such as the deviance information cri-
teria (DIC), which have proven difficult to use in models using missing data approaches,
such as mixture and random effects models (Celeux et al., 2006). In our case, not only do
we utilize random effects, our model is a special case of mixture model (a hidden Markov
model). Hypothesis testing and model selection are crucial to wide use of these models,
and is an area of future work.
In our motivating example using a smoking cessation study, we note a possible differ-
ence between the hidden state 3-2 transition probabilities in the placebo and treatment
groups. This was a somewhat surprising result, as we would normally expect the treatment
group to have a beneficial effect, when here it appears it may not. Given the relatively
good performance of our method in the simulation study in this paper, which are fairly
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representative of the data generated from the motivating study, we are confident this noted
difference is not due to a computational issue with our methodology. It is quite possible
that the difference estimated in models III and IV for p132 and p
0
32 is due to some unmod-
eled missing data mechanism, and is an area we are currently investigating. Also, we note
that in O’Malley et al. (2007) a treatment effect on smoking cessation for the entire study
sample was not found.
Lastly, although maximum likelihood methods could be used for fitting models such as
the ones presented in this paper, we have found, in general, that a Bayesian approach using
MCMC is vastly more computationally efficient. We were able to use such methods, where,
for example, a two hidden state (M = 2) model was fit by approximating the integration in
equation (1) by Gauss-Hermite quadrature, and maximizing the approximated likelihood.
This required at least 140 quadrature points, and took several days (>3) using a state of the
art computer. Alternatively, the models presented in Table 4, some of which have over twice
the number of parameters as the model fit by maximum likelihood, took approximately 9
hours to compute on the same computer.
This improvement in computational efficiency, along with the flexibility and general
applicability of such models, provides a great opportunity for future work and applications
to other disease areas and problems.
3.7 Appendix: Markov Chain Monte Carlo Conver-
gence Diagnostic Plots
3.7.1 Trace and Density Estimation Plots
In order to assess stationarity and mixing of the MCMC sampler, we generated trace and
density estimate plots for each of the 24 main parameters (Θ) from a randomly selected
run of our simulation runs in section 3.4 from situation (2). These plots were generated
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using the coda package in R and are presented in Figures 3.2-3.7.
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Figure 3.2: Trace and density estimate plots for parameters (from top to bottom): π1
(var1), π2 (var2), p
0
12 (var3) and p
0
13 (var4).
Overall, there does not appear to be any strong indication that the Markov Chain has
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Figure 3.3: Trace and density estimate plots for parameters (from top to bottom): p021
(var1), p023 (var2), p
0
31 (var3) and p
0
32 (var4).
not reach stationarity. The sampling procedure seems to mix reasonably well. Further, we
do not note any multi-modality or phenomena consistent with label switching, although
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Figure 3.4: Trace and density estimate plots for parameters (from top to bottom): τ11
(var1), τ12 (var2), τ13 (var3) and τ21 (var4).
in this same situation in other simulated runs (from different simulated datasets), label
switching did occur.
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Figure 3.5: Trace and density estimate plots for parameters (from top to bottom): τ22
(var1), τ23 (var2), Σ11 (var3) and Σ21 (var4).
3.7.2 Auto-correlation function plots
Using the same MCMC sample as done in section 3.7.1, we also generated estimates for
the auto-correlation function within each posterior sample to assess mixing.
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Figure 3.6: Trace and density estimate plots for parameters (from top to bottom): Σ22
(var1), 1
σ2ε
(var2), p112 (var3) and p
1
13 (var4) .
Overall, the estimated auto-correlation function decreases with lag significantly, and
the auto-correlation within a variable is quite negligible by lag 5 in many such parameters.
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Figure 3.7: Trace and density estimate plots for parameters (from top to bottom): p121
(var1), p123 (var2), p
1
31 (var3) and p
1
32 (var4).
The most persistent auto-correlations are generally observed in components of τ , which is
not surprising, as the full conditional distributions of these parameters are dependent on
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Figure 3.8: Auto-correlation function plots for the MCMC sampling approach for param-






21 (5) and p
0
23 (6).
both the random effects bi, and the hidden states, Zi.
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Figure 3.9: Auto-correlation function plots for the MCMC sampling approach for param-
eters: p031 (7), p
0
32 (8), τ11 (9), τ12 (10), τ13 (11) and τ21 (12).
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Figure 3.10: Auto-correlation function plots for the MCMC sampling approach for param-













































































Figure 3.11: Auto-correlation function plots for the MCMC sampling approach for param-













Using Multivariate MHMMs for
Classification of the Disease States
4.1 Background
In Chapter 3, we outlined a modeling framework that extended the work of others (Altman,
2007) from modeling univariate longitudinal data as a hidden Markov model (HMM) with
between-subject heterogeneity in the observed process to the setting of multivariate lon-
gitudinal data. Thus far, we have focused on drawing inference from the population-level
parameters governing these models. Under a MHMM, these parameters can be much more
informative than those derived from models which ignore either the dynamic hidden states,
or the between-subject heterogeneity. Indeed, much of the computational complexity of
these models is generated due to the observation- or subject-specific differences generated
from the hidden Markov process, or the random effects. In this chapter we will examine
if the hidden states can be used effectively to draw inference to meaningful disease states.




As is the case in Chapter 3, we will return to our motivating example of a smoking ces-
sation clinical trial, which evaluated a pharmacological intervention to assist people in
abstaining from smoking. The results in that chapter generally corresponded with the
clinical information used to design such clinical trials. In particular, we found that the
population modes of the observed longitudinal response corresponding to their respective
underlying (but still at that point hypothetical) hidden disease states were quite well sep-
arated. Reassuringly, under model (I) in Table 3.6 in that chapter, for an individual with
the relevant random effect set at zero, the three modeled hidden disease states correspond
with probabilities of smoking on a given day of 0.005, 0.22 and 0.66, respectively. These
roughly correspond with barely smoking at all, smoking one or two days a week, and smok-
ing about five days a week, respectively. Similarly, the carbon monoxide (CO) population
means when untransformed by inverting the (log[Y + 1]) transformation, correspond with
CO levels of 2.26, 3.63 and 12.95 ppm for hidden states, one, two and three, respectively.
It is important to contrast these estimates with thresholds used in the actual study
to define the study’s two disease states – abstinence and smoking. While the study time
period where these definitions are applicable can change, in general, any self-reported
smoking or a CO observation exceeding ten ppm (or, in some studies, that threshold is
set lower, at eight ppm) defines smoking, regardless of any other possible mitigating fac-
tors. Under our model, the population modes of the lowest smoking (hidden state 1) and
the highest smoking (hidden state 3) states have a close correspondence with the study
definitions. Ignoring between-subject heterogeneity of these observed responses, the rates
of misclassification should be minimal between these hidden and study disease states. On
the other hand, the intermediate hidden state (state 2) has population-level means cor-
responding with smoking in the self-reported count, and abstinence in the CO response.
Some further justification is required before further interpreting inference drawn from the
hidden states to those of the diseases states typically found in smoking cessation studies.
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This would include how well each hidden state corresponds with some known evaluable
definition of disease state. Further, discrepancies may suggest other adjustments to the
modeling approach or potential changes to disease state definitions.
Additionally, while the benefits of modeling multivariate longitudinal data are well
described, it is unclear under the modeling framework we described in Chapter 3 if im-
provements are seen by including additional responses. We will begin with this element,
and examine if a multivariate model following a MHMM with separate but correlated
random effects for each response can be justified over the univariate response alternatives.
4.3 Model Considerations
4.3.1 Methodology
In this chapter we will continue to work with one of the examples from the motivating ex-
ample in Chapter 3. In Chapter 3, we initially fit using maximum likelihood estimation (via
a Gauss-Hermite approximation to the marginal likelihood) a model which considered a
bivariate longitudinal response involving cigarette smoking counts and a continuous trans-
formed (log[Y + 1]) longitudinal CO levels. Under the Gauss-Hermite approximation, we
were able to fit a two hidden-state Markov model, with separate but correlated zero-mean
multivariate normal random effects in the observed longitudinal process by extending the
work of others in the univariate settings (Altman, 2007). Increasing the hidden state space
would have also significantly increased the computing time, as not only would the com-
putation of the forward probabilities be more computationally complex, approximating
the gradient or Hessian (when required, for instance, in computing approximate standard
errors for the estimates) would require significantly more evaluations of the likelihood.
We will return to using the cigarette count response in this chapter as further illustra-
tion on how the Bayesian methodology in Chapter 3 can be expanded to handle several dif-
ferent types of responses. Further, we believe that in many situations the cigarette counts
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will contain more information than using the number of days in the previous week a person
smoked, the latter approach used in Chapter 3, where focus was more on demonstrating
the methodology as compared to the strategy in this chapter of a more comprehensive
consideration of modeling the smoking cessation data.
As was the case in Chapter 3, let Zit denote the hidden process for subject i, (i =
1, 2, . . . , N) at some discrete time points t, (t = 1, 2, . . . , ni). Further, denote Zi to com-
prise all values of Zit for subject i, and Z to be all values of Zi across all i. Assume Zit
arises from an M−state Markov chain with transition matrix P and initial probability
vector, π. Again, we will primarily focus on HMMs arising from first-order time homoge-
neous Markov chain hidden processes, where P (Zit = k|Zi,t−1 = j) = pjk for all t > 1, and
P (Zi1 = k) = πk, where j, k = 1, . . . ,M . As was the case in Chapter 3, we will consider
models with a hidden state space of three (M = 3).
Let yit denote a bivariate longitudinal response for subject i at time t, such that
yit = [yi1t, yi2t]
′
, where the first response is a count of cigarettes in week t over a ait day
period, and as was the case in Chapter 3, the second response is a CO level reading.
Similar to above, let yi denote all the observations for subject i across all longitudinal
responses and time points, and y be the collection of all yi for i = 1, 2, . . . , N .
We will follow the same framework as Chapter 3, but apply the new weekly cigarette
count response (Yi1t) as a Poisson count with logarithmic link function in place of the
number of days smoked response such that:







i1tkbi + log(ait) and,









As was the case in Chapter 3, Yi2t is the transformed (log[Y +1]) CO-levels for subject i
and time t, and τr represents the fixed effect intercept term for each hidden state, as defined
through an M -dimensional hidden state vector, Hirtk (which is dependent on Zit), xirt is
a vector of covariates at time t for subject i when Zit = k for the r
th longitudinal response.
The associated fixed effect coefficient parameters for the covariates are represented by βrk,
which also could vary over different values of the hidden process. We will again repeat a
similar set of assumptions, where bi
iid∼ MVN(0,Σ), and will use separate, but correlated
random effects, where wi1tk = [1, 0] and wi2tk = [0, 1] for all i, k and t. Here, an offset
term of log(ait) is used to account for the slightly different number of days between study
visits for each individual (usually six or seven).
As we demonstrated in Chapter 3, such a model can be fit by Gibbs sampling. The
procedure which updates the hidden states outlined in section 3.3.2 can be applied after
updating the forward probabilities to use a Poisson response for r = 1 in place of the
binomial response used in Chapter 3.
Using Gibb sampling, we sample from the posterior, [β, τ ,P ,π,Σ, σ2ε , b, z|y], by sam-
pling from the following conditionals: [τ1,β1|y, b, z], [τ2,β2|y, σ2ε , b, z], [P |z], [π|z], [Σ|b],
[ 1
σ2ε
|y,β, τ , b, z], [b|y,β, τ , b, z,σ2ε ], and [Z|y,β, τ ,P ,π, σ2ε , b].
Once Zi is updated for each i as outlined in section 3.3.2, the following can be sampled
as:































[π(s)|z] ∼ Dirichlet(ζ(s)π + q(s)),
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t=1 1(zi1 = m, vi = s),
[P (s)u |z] ∼ Dirichlet(ζ(s)u + q(s)u ), where P (s)u is the uth row of P (s),






1(zit = m, zi,t−1 = u, vi = s),























































× (P + c) matrix(c being the length of xi2t)
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with [τ1,β1|y, z, b] and [bi|yi, zi,β, τ , σ2ε ] sampled using a Metropolis within Gibbs step.
Based on this Gibbs sampling approach, we fit this model, and present the posterior
means and standard deviations for each of the parameters in Table 4.1. Further, to com-
pare this bivariate modeling approach to the two component univariate models, we also
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fit these univariate models (cigarette counts only and CO levels only) separately. These
models can be done quite easily by ignoring the unused response’s parameters, and adjust
how sampling of the hidden states, Zit, and random effects, bi are conducted. For example,
for the cigarette-only count model, we can eliminate sampling from the [τ2,β2|y, z, b, σ2ε ]
and [ 1
σ2ε
|y,β2, τ2, b, z] full conditional distributions, and modify the random effects covari-
ance structure, Σ to be one-dimensional with its corresponding prior (can remain inverse-
Wishart, or its equivalent Gamma distribution form), with corresponding one-dimensional
zero-mean, normal prior. Updating the hidden states involves modifying the forward prob-
ability formulas, only by ignoring the normally distributed (CO) response, which can be
done quite easily. Lastly, sampling from [bi|yi, zi,β, τ , σ2ε ] can be done by modifying the
bivariate full conditional to be:

































The results of the two univariate models are presented along side the bivariate models in
Table 4.1. Of particular note, are the stark differences between the transition matrices and
population intercepts of the univariate self-reported (SR) count-only model, and the joint
bivariate model. In the case of the univariate SR count-only model, the population modes
τ1 are quite a bit lower, which for an individuals with a the relevant random effect equal
to zero correspond with a smoking rates of 0.002, 0.030 and 0.085 cigarettes per day in
the first, second and third hidden states, respectively. This is much lower than one would
expect these rates to be, where for instance only 20 (5.6%) study participants reported
smoking fewer than ten cigarettes on the day of randomization. In this case, most of the
heterogeneity of the observed response is modeled via the random effects, where we observe
a large between-subject heterogeneity, with Σ11 = 9.6023. Further, when we predict the
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one-dimensional random effects, bi by their posterior means, and look at the distribution in
Figure 4.1, we find one which is heavily skewed to the right, with many subjects predicted
as having a random effect of around −2. This group of individuals are subjects with very
homogeneous self-reported cigarette count longitudinal trajectories, where they claim they
were abstinent throughout the entire study period. On the other hand, the patients who do
transition to the non-abstinent states are modelled mainly through the heterogeneity in the
random effects. For instance, for the two subjects with random effects predicted to exceed
six, both subjects dropped out after the first study visit. In the one week of available data,
the first subject was predicted to have daily self-reported smoke rates of 0.841, 15.385 and
44.153 in the first, second and third hidden states, respectively. They reported smoking
310 cigarettes over 7 days, for an average daily total of 44.286 cigarettes/day. The second
subject had predicted daily self-reported cigarette rates of 0.708, 12.953 and 37.174, and
reported smoking on average 37.333 cigarettes per day. In both cases, the predicted rates
in the highest hidden state correspond well with the observed values, but the separation
of the population means corresponding with the hidden states are not very qualitatively
different. Further, the distribution of the posterior mean of the random effects is heavily
skewed, suggesting poor model fit.
We also conducted an analysis using only the univariate CO-only response. The results
of this analysis (see Table 4.1) are generally consistent with those presented in Chapter
3, with a couple noted exceptions. First, we note that the second and third hidden state
population modes are quite a bit higher than what was reported in Chapter 3. In Chapter
3, we estimated the modes to be 2.26, 3.63 and 12.95 for the first, second and third hidden
states, respectively, but here they are estimated to be 2.07, 6.21 and 19.72, respectively,
which is much higher in all but the lowest hidden state. The between-subject heterogeneity
as modeled through Σ22 is about half of that reported in Chapter 3’s analyses. In general
terms, the posterior means of the random effects are reasonably symmetric about zero,
and roughly normal.
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Table 4.1: Comparison of the bivariate and the two univariate models
Parameter SR Count Only CO Only Bivariate Model
π1 0.4353 (0.0763) 0.8084 (0.0293) 0.7130 (0.0297)
π2 0.2572 (0.0617) 0.1545 (0.0283) 0.2146 (0.0289)
p012 0.1444 (0.0634) 0.0342 (0.0150) 0.0442 (0.0174)
p013 0.0643 (0.0408) 0.0115 (0.0067) 0.0136 (0.0077)
p021 0.1985 (0.0963) 0.1556 (0.0746) 0.2072 (0.0719)
p023 0.4081 (0.1190) 0.0834 (0.0481) 0.1745 (0.0598)
p031 0.2369 (0.0911) 0.1810 (0.1411) 0.1241 (0.0786)
p032 0.1635 (0.1135) 0.3420 (0.1771) 0.0877 (0.0796)
p112 0.1144 (0.0394) 0.0424 (0.0096) 0.0349 (0.0084)
p113 0.0640 (0.0283) 0.0067 (0.0036) 0.0083 (0.0037)
p121 0.1822 (0.0696) 0.0940 (0.0355) 0.2515 (0.0486)
p123 0.3746 (0.0822) 0.0700 (0.0268) 0.2271 (0.0437)
p131 0.2515 (0.0602) 0.1511 (0.0781) 0.0650 (0.0307)
p132 0.2435 (0.0603) 0.1647 (0.0914) 0.2007 (0.0501)
τ11 -6.4294 (0.4740) - -5.2899 (0.2120)
τ12 2.9067 (0.1597) - 4.4679 (0.2035)
τ13 1.0543 (0.0495) - 1.3101 (0.0434)
τ21 - 1.1207 (0.0210) 1.1851 (0.0221)
τ22 - 0.8546 (0.0446) 0.2959 (0.0474)
τ23 - 1.0557 (0.0752) 0.8782 (0.0569)
Σ11 9.6023 (1.8137) - 2.3318 (0.4179)
Σ12 - - 0.1242 (0.0459)
Σ22 - 0.0526 (0.0083) 0.1048 (0.0111)
1
σ2ε
- 11.4430 (0.5777) 8.6795 (0.3676)
Each value is the posterior mean (posterior standard deviation), where πk is the initial
probability of hidden state k, psjk is the j, k transition probability for the s
th treatment
group for the hidden states, τrk is the intercept term for response r and hidden state k, Σ
is the covariance matrix of the random effects, and σ2ε is the residual error associated with
response 2.
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Figure 4.1: QQ-normal plot and histogram for the posterior mean of bi for the self reported
cigarette count-only univariate response MHMM model
An interesting comparison of the sources of heterogeneity in the CO response can be
conducted by using some pre-treatment data collected in this study. The study investi-
gators collected up to two screening CO levels, and one baseline measurement, where the
subjects were known to be currently smoking. This provides a very homogeneous set of
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Figure 4.2: QQ-normal plot and histogram for the posterior mean of bi for the CO-only
univariate response MHMM model
observations in terms of disease states which we can compare the variance components
estimated under a MHMM to. We fit a simple linear mixed effects model with a random
intercept and fixed time effect with the nlme package in R to these data such that:
Yi2t = γ0 + bi + γ1tit + εit (4.3)
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Figure 4.3: QQ-normal plot and histogram for the posterior mean of bi for the bivariate
response MHMM model
for t ∈ {−2,−1, 0}, bi
iid∼ N(0,Σ22) and εit
iid∼ N(0, σ2ε ). We assessed these estimates to
those derived from the CO-only response model in Table 4.1. Under (4.3) the pre-treatment
data provides estimates of γ̂0 = 3.1925, γ̂1 = −0.0005, Σ̂22 = 0.0929, and 1σ̂2ε = 16.1296.
The estimate of Σ22 corresponds closely with those we have estimated in the MHMM-
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based models. On the other hand, γ̂0 = 3.1925 corresponds with a untransformed CO
level of 23.35 which is almost double that which we have previously reported, suggesting
that CO levels in this pre-treatment period may not represent those we observe during the
treatment period. In fact, we rarely see CO-levels above 20 during the treatment period,
with only 21 longitudinal observations exceeding this threshold. Lastly, under (4.3), 1
σ̂2ε
is
a little higher than what we estimate elsewhere, suggesting there is smaller residual error
during the pre-treatment period, which probably isn’t surprising, as we would expect less
of this source of heterogeneity under a more constant disease status, where the response
may be slightly lagged behind disease status. This analysis was meant to be illustrative
only and in principle could include other covariate effects, in addition to a random time
effect, but was fit to (4.3) mainly for a simple comparison to the models in Table 4.1.
4.4 Classifying the Hidden States
In general, during a clinical study when disease states are classified by using cutoffs of
some surrogate endpoint or biomarker, it may be difficult to determine the true state of
the clinical outcome precisely. Likewise, when using hidden state approaches such as the
ones outlined through this chapter and Chapter 3, except in cases of simulated data, it
will be difficult to evaluate the utility of inference about these hidden states as a classifier
for the true underlying disease states. As discussed in section 4.2, these hidden states
may in some manner closely resemble the thresholds on the observed responses. With
that said, one would expect that inference drawn from hidden state approaches would
roughly correspond with the disease states determined by cutoff approaches (i.e., they
would agree most of the time). When there lacks agreement between the two approaches,
this might illustrate inadequacies of either the modeling approach, the cutoff protocol,
or both. With this in mind, in this section, we will discuss a framework for evaluating
inferences pertaining to the hidden states, when cutoffs are used to define hidden states.
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We will evaluate the agreement of these cutoff-defined disease states, treating the study-
defined disease states as a ’gold-standard,’ noting that in smoking cessation studies, the
only true gold standard would be 24-hour surveillance, which is both impractical and may
not generalize to other populations or settings.
4.4.1 Methodology
The inference we can conduct for the hidden states is mainly generated from a function of
the state or locally decoded probabilities:







it = k) , (4.4)
where Z
(j)
it is the simulated value of the j
th iteration of the MCMC algorithm for J total
iterations. From each observation time, we get a vector of M probabilities, and will denote
this φit = [φit1, φit2, . . . , φitM ] with
∑M
m=1 φitm = 1 for each i and t. There are other ways to
compute these quantities, but this one does not require any additional computation during
the MCMC algorithm, and can be quickly and efficiently processed from the MCMC output
once the simulation is completed.
We also define the most probable state as a maximum a posteriori estimator for each
hidden state as:
δ̂it = argmax φ̂itk
k∈{1,2,...,M}
, (4.5)
which can take on any of the discrete values in the hidden state space, such that δ̂it ∈
{1, 2, . . . ,M}, with its value representing the state with highest probability compared to
each of the alternatives individually.
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4.4.2 Results
Using the study-defined disease as a so-called ’gold standard’, we will examine the utility
of using φ̂it and δ̂it as a framework to do inference about the disease states. First, we look
at how δ̂it corresponds with different possible study definitions of smoking. These results
are presented in Table 4.2, where each weekly observation is classified according to several
study definitions as being a smoking or a non-smoking observation. These results are
cross-tabulated against the constant δ̂it values for each observation. We note that generally
the models based on a univariate self-reported response or the bivariate response model
perform the best, with the CO-only model generally performing the poorest across almost
all scenarios. We report two different calculations of accuracy, with agreement assessed in
all observations, equating δ̂it = 2 with smoking observations, and strict agreement which
assesses only those observations with δ̂it = 1 or 3. The relatively strong performance of the
univariate SR only model is somewhat surprising as the results in Table 4.1 were slightly
unexpected, and the model fit appeared to be poor (see Figure 4.1). We believe this may
be due to the absence of CO data, whereby a model fit using only SR is going to be very
sensitive to any non-zero SR observations which defines many of these study definitions.
In the bivariate case, many of the misclassified observations appear to be at least partly
due to δ̂it = 1 allowing some observations with a small SR count of 1-7 cigarettes in a week,
and strict definitions of smoking abstinence would obviously preclude these observations.
We will explore these discrepant cases in more detail later.
Next, using φ̂itk as a classifier we will assess classification performance by receiver op-
erating characteristic (ROC) curves. Figures 4.4 - 4.9 present the ROC curves for each of
the three models considered thus far (the two univariate models and one bivariate model)
broken down by study visit, with area under the curve (AUC) reported for each. Figures
4.4-4.6 use φ̂it1 as a classifier for the study definition of smoking abstinence used in the
motivating smoking cessation study (SR=0 and CO≤10). Figures 4.7-4.9 use φ̂it3 as a clas-
sifier for the study definition of smoking used in the motivating study (SR>0 or CO>10).
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Table 4.2: Breakdown of most probable disease states by different study-defined disease
states under separate univariate and bivariate models
Definition of Smoking Univariate SR Only Univariate CO Only Bivariate
SR>0 or CO>10
NS S
δ̂it = 1 1291 64
δ̂it = 2 16 102




δ̂it = 1 1183 240
δ̂it = 2 127 171




δ̂it = 1 1295 118
δ̂it = 2 17 196





δ̂it = 1 1321 34
δ̂it = 2 31 102




δ̂it = 1 1291 132
δ̂it = 2 146 152




δ̂it = 1 1388 25
δ̂it = 2 43 170





δ̂it = 1 1273 82
δ̂it = 2 16 102




δ̂it = 1 1183 240
δ̂it = 2 109 189




δ̂it = 1 1280 133
δ̂it = 2 16 197





δ̂it = 1 1334 21
δ̂it = 2 65 53




δ̂it = 1 1373 50
δ̂it = 2 196 102




δ̂it = 1 1401 12
δ̂it = 2 145 68





δ̂it = 1 1307 48
δ̂it = 2 17 101




δ̂it = 1 1183 240
δ̂it = 2 143 155




δ̂it = 1 1307 106
δ̂it = 2 19 194
δ̂it = 3 7 148
Strict Agreement: 92.8%
Agreement: 92.9%
SR is weekly self-reported smoking; CO is the weekly CO level; NS are non-smoking
observations; S are smoking observations; δ̂it is the most probable hidden state classifier
from (4.5).
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Generally, the bivariate model has a higher AUC in all but one of the instances, with the
univariate model using only the CO levels having the poorest performance. We also note
a lack of concavity in Figure 4.7, and believe this to be at least partially attributable to
the intermediate hidden state.
In Figure 4.10 we represent all four cases (on three distinct subjects) noted in the SR>0
or CO>10 case for the bivariate model fit in Table 4.2 in longitudinal panels for each
patient where the most probable hidden state was state three, but the study definition
defined the visit as being non-smoking. In each row we have each of the longitudinal
responses and locally decoded probability, P (Zit = 3|yi, bi,Θ) of being in the third hidden
state at each study visit. In the first subject, we have a subject where the last two CO
measurements are significantly elevated relative to the first three measurements, despite
the patient reporting they did not smoke, and CO levels remaining below ten. This would
suggest that the hidden states are somewhat sensitive to relative changes in CO levels
over the study period, and is again seen in the next two subjects, where the first one
is not accompanied by a corresponding SR smoking event, but the last one is. We see
a possible strength in this analysis approach, where unexplained significant increases in
CO levels relative to other periods are more easily detected when compared to using a
hard >10 threshold as was done in the study. Additionally, while only one of these cases
was corresponded with SR smoking, the magnitude that P (Zit = 3|yi, bi,Θ) was seen to
increase was also the greatest in this instance. These are the only four cases where the
model would have predicted smoking by classifying each state on the maximum locally
decoded probability.
Alternatively, Figure 4.11 is an illustrative, but representative sample of five subjects
which had a maximally locally decoded probability state of hidden state one, while the
subject was determined to have smoked according to the study definition. In many in-
stances these discrepancies can be explained by (often single isolated) study weeks where

























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 4.10: Example longitudinal plot for subjects with one or more visits such that the
most probable hidden state according to the MHMM bivariate longitudinal model was
state three, despite it being a non-smoking visit according to the study definition.
Solid circles represent cases where state three was the most probable state, but the study
definition defines this as being a non-smoking visit. The grey line in the rightmost plots
represents P (Zit = 1|yi, bi,Θ), whereas the black line represents P (Zit = 3|yi,Θ). The
dotted line in the leftmost plot represents the study-defined CO cutoff of ten.
87

































































































































































Figure 4.11: Example longitudinal plot for subjects with one or more visits such that the
most probable hidden state according to the MHMM bivariate longitudinal model was
state one, despite it being a smoking visit according to the study definition.
Solid circles represent cases where state one was the most probable state, but the study
definition defines this as being a smoking visit. The grey line in the rightmost plots
represents P (Zit = 3|yi, bi,Θ), whereas the black line represents P (Zit = 1|yi, bi,Θ). The
dotted line in the leftmost plot represents the study-defined CO cutoff of ten.
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cigarette smoked during the week, have maintained low CO levels during the week, and
report smoking abstinence in the following visits. A case of this happens in each of the
five examples in Figure 4.11, most often occurring during the first two weeks. Frequently,
study definitions of smoking abstinence allow for a grace period during the first couple of
study visits, and these would be largely ignored. While often occurring during the first
few weeks, these discrepancies between the most probable hidden state and study-defined
state do occur in weeks three through six, where, for example, the third row of plots il-
lustrates a subject with all but one week with relatively low self-reported smoking, while
maintaining relatively low CO levels. In this sense, the hidden state decoding is somewhat
forgiving to low self-reported smoking while low CO levels are maintained, and no con-
tinued increases are noted. This is again evident in Table 4.2 where modifying the study
definition to include weeks where only one cigarette was smoked increases the agreement
and strict agreement from 92.5% and 92.2% to 95.8% and 97.6%, respectively. Of the 118
observations with a discrepancy between the most probable state being state 1, with a
study-defined status of smoking, 93 are explained by observations of one cigarette smoked
in a week defining smoking status. About half (13 observations) of these remaining 25
discrepant observations, result when a subject smoked seven or fewer cigarettes in a week,
and the model classified them in hidden state one. The remaining 12 observations are ac-
counted by slightly elevated CO levels, with six of these remaining discrepancies occurring
at a CO level of 11, and all occurring below 17.
An interesting case is that of the last row (subject) in Figure 4.11, where at week 3
the subject reports smoking 16 cigarettes, but maintains a low CO level, and reports no
smoking during the rest of the study visits. This one week of smoking is accompanied
by a stark decrease to nearly zero for P (Zit = 1|yi, bi,Θ), but relatively no change in
P (Zit = 3|yi, bi,Θ), indicating that this observation would be one which has a most
probable hidden state classification of two. This is both reassuring and problematic. It is
reassuring, because changes in one of the component smoking measures can be detected
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effectively, such that the model would not classify this observation as a hidden state 1
observation. We had already seen a case where relative changes in CO levels were detected
as smoking, even when self-reported smoking remained non-existent, and this illustrates
the other case, where CO levels remained low, but self-reported smoking was detected as
non-abstinent. On the other hand, conventional wisdom would generally conclude that this
was a clear case of someone relapsing, but the bivariate MHMM classifies this observation
as being most probably in the intermediate state. This is probably due to two separate but
important issues. The first is likely that the subject returns to self-reported abstinence in
the immediate following weeks. The second is likely that the relapse is not accompanied
by a CO level increase, most probably because the smoking occurred out of the window of
detection. We rest on the side of reassurance, even if we are not entirely convinced that this
observation is emblematic of intermediate smoking state visit, mainly because to classify
this observation as a non-smoking state visit would have been a worse classification. Much
of this is caused by the lack of a study-defined disease state which would closely correspond
with hidden state two, and it is difficult to draw comparisons between this hidden state and
findings in the study. As we argue above, the second hidden state resembles the smoking
state much more so than the non-smoking state both conceptually, and empirically, that
concluding an observation such as this one being in hidden state two is less of an error
than concluding that it is in hidden state one, which there is much evidence against.
4.5 Assessing the Conditional Independence Assump-
tion
Throughout this thesis, we have been relying upon several conditional independence as-
sumption to simplify the modeling approach. One assumption we would like to be able
to assess is the independence of the random effects from the hidden states. One way of
doing this is by plotting the posterior mean for each subject’s random effect by the most
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probable hidden state (δ̂it) at each study visit. These plots are done in Figures 4.12 for
the Poisson SR count response (r = 1) and 4.13 for the Normal CO level response (r = 2),
and are done for the bivariate model examined in sections 4.3.2 and 4.4.2
As can be seen in Figures 4.12 and 4.13, there may be a small dependence of the random
effects on the random effect. In general, the predicted random effects for observations with
δ̂it = 1 have their median below zero, for both responses. This is relatively small when
compared to the overall variance of the random effects distributions, and while the variance
of the random effect distribution does seem to fluctuate over the study visits, there is no
systematic pattern dependent on the most probable hidden state. While boxplots for
δ̂it = 1 do seem to have a larger number of outliers as defined by the boxplots, it also has
the largest number of observations, which may explain this in part.
4.6 Simulation Study
In order to assess the classification properties of these methods, we conducted a simulation
study. We consider two different situations, with the first situation representing a baseline
to compare the latter to. Our first situation is the standard MHMM model where none of
the model assumptions are violated. The second situation resembles a scenario when the
data are contaminated by some unmodelled external process which is dependent on the
hidden process. In this second case, two of the hidden states are contaminated at some
rate such that they resemble the third hidden state. This would correspond to an area of
concern for our motivating dataset, where some observations may have under-reported SR
cigarette counts, or high CO-levels were undetected given its short detection half life.
With this in mind, every run in each of the situations was fit first with the two separate
component univariate longitudinal MHMM models, and then with the bivariate model,
with 100 runs of each done according to the methodology described in section 4.3.1. The






































































































































Figure 4.12: Box plot for the Poisson SR count response (r = 1) random effect at each












































































































































Figure 4.13: Box plot for the normal CO level response (r = 2) random effect at each
study visit stratified by the most probable hidden state, δ̂it.
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1. The data are generated from a MHMM according to (4.1) and (4.2) with τ1 =
[−3, 2, 1.5] and τ2 = [1.2, 0.5, 0.8]. As was the case in Chapter 3, we will consider
the case where the hidden states are generated as a first-order Markov Chain with a













, with π = [0.60, 0.25, 0.15]. The random effects are i.i.d zero
mean multivariate normal with covariance matrix, Σ = [ 2.0 0.20.2 0.1 ], and the inverse of
the variance of the residual error in the second response is 1
σ2ε
= 10.0
2. The data for the hidden states are generated as in situation (1) with the same
transition probability matrices and initial probability vector. Conditional on the
hidden states, we generated another latent (but unmodeled) source of variation,
which contaminates the model, such that Dirt|Zit = k
iid∼ Bernoulli(κrk), with κr1 =
0, and κrk = 0.1 for k > 1 and r = {1, 2}, such that (4.1) and (4.2) is modified to
have:







i1tbi + log(ait) + (−2)Di1t







i2tbi + (−0.5)Di2t .
Note that the Dirt are sampled independently for each r conditional on Zit, and the
rest of the parameters are set according to the specification in situation (1).
The resulting parameters estimates from each of these situations under univariate and
bivariate MHMMs are presented in Tables 4.3 - 4.4.
In Table 4.3 we examine situation (1), and note bias in many parameter estimates
under both types of univariate response models, and sometimes this can be quite severe.
In all parameters, the bivariate model, which incorporates both of the univariate models’
responses exhibits less bias, and in some cases significantly less bias. The one exception
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Table 4.3: Comparison of the bivariate and the two univariate models under simulation
through 100 simulation runs for Situation (1)
Parameter True Value SR Count Only CO Only Bivariate Model
π1 0.60 0.4953 (0.0880) 0.6105 (0.1514) 0.5919 (0.0498)
π2 0.25 0.2930 (0.0820) 0.2290 (0.1417) 0.2509 (0.0504)
p012 0.10 0.2149 (0.1118) 0.1823 (0.1748) 0.1052 (0.0457)
p013 0.05 0.1063 (0.0595) 0.0700 (0.0466) 0.0548 (0.0211)
p021 0.20 0.2857 (0.1115) 0.3260 (0.2064) 0.2240 (0.0984)
p023 0.20 0.2580 (0.0939) 0.2716 (0.1790) 0.2344 (0.0870)
p031 0.10 0.1224 (0.0500) 0.1196 (0.0689) 0.1053 (0.0413)
p032 0.10 0.1447 (0.0688) 0.1385 (0.1180) 0.1166 (0.0509)
p112 0.10 0.1681 (0.0643) 0.1691 (0.1616) 0.1000 (0.0282)
p113 0.05 0.0940 (0.0382) 0.0647 (0.0369) 0.0515 (0.0132)
p121 0.20 0.2385 (0.0813) 0.3196 (0.1724) 0.2038 (0.0552)
p123 0.20 0.2329 (0.0703) 0.2193 (0.1215) 0.2109 (0.0440)
p131 0.10 0.1213 (0.0585) 0.1322 (0.0838) 0.1066 (0.0342)
p132 0.30 0.2882 (0.0753) 0.2670 (0.1176) 0.2942 (0.0483)
τ11 -3.00 -3.4546 (0.4085) - -3.0245 (0.1947)
τ12 2.00 2.0566 (0.2933) - 2.0220 (0.1830)
τ13 1.50 1.4987 (0.1393) - 1.5047 (0.0928)
τ21 1.20 - 1.2674 (0.0445) 1.2080 (0.0302)
τ22 0.50 - 0.4125 (0.2364) 0.4795 (0.0572)
τ23 0.80 - 0.7558 (0.2155) 0.7899 (0.0475)
Σ11 2.00 2.4849 (0.3758) - 1.9692 (0.2659)
Σ12 0.20 - - 0.2032 (0.0446)
Σ22 0.10 - 0.1220 (0.0153) 0.1043 (0.0129)
1
σ2ε
10.00 - 8.8300 (0.5682) 9.5031 (0.4939)
Each value is the average posterior mean (average posterior standard deviation) of the
simulated sample. πk is the initial probability of hidden state k, p
s
jk is the j, k transition
probability for the sth treatment group for the hidden states, τrk is the intercept term for
response r and hidden state k, Σ is the covariance matrix of the random effects, and σ2ε is
the residual error associated with response 2.
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would be that of the estimate for τ13, where the univariate SR count only model has
slightly smaller bias than the bivariate model. In both cases, the bias is very small, and
not problematic in either case. These univariate results bear some resemblance to the
bias we observed in some of the simulations conducted in Chapter 3 under the bivariate
model. Further exploration of this bias, suggested that it was a function of how well-
separated the hidden state modes of the observed response were, the amount of between-
subject heterogeneity, and the number of observation times per subject. The results here,
generally support these conclusions, although it is difficult to quantify the role of the mode
separation and between-subject heterogeneity under these different univariate response
models. The inflated between-subject heterogeneity as estimated through Σ11 and Σ22 is
also interesting. This would be generally consistent with the results we presented in Table
4.1 where we saw the univariate SR only model describe the heterogeneity through the
random effects, and not to nearly the degree expected through the hidden states. With
the limited number of observation times per subjects and multiple sources of heterogeneity
being modeled, this class of model seems to shrink the components of P toward the prior
mean, and compensate by increasing the variance of the random effects. As we noted in
Chapter 3, placing an informative prior on the components of P seemed to significantly
reduce the amount of bias observed. Lastly, we note that under the bivariate model, the
bias is significantly less. In addition to increasing the number of observation times (ni),
and using an informative prior, this study would also suggest that adding an additional
response may assist in reducing any bias observed.
In Table 4.4 under situation (2), we note a similar difference between the the bivariate
and univariate models. With the exception of p032 and τ12, the bivariate model has lower
bias than each of the univariate models. We generally note that when bias was observed in
Table 4.3, we tend to see higher bias in Table 4.4 introduced by the contamination process.
With this contamination being hidden state dependent, under the univariate model fits it
is perhaps not surprising to see additional bias introduced to some of the the transition
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Table 4.4: Comparison of the bivariate and the two univariate models under simulation
through 100 simulation runs for Situation (2)
Parameter True Value SR Count Only CO Only Bivariate Model
π1 0.60 0.5088 (0.1045) 0.6360 (0.0812) 0.6351 (0.0605)
π2 0.25 0.2907 (0.0958) 0.2154 (0.0752) 0.2230 (0.0578)
p012 0.10 0.2424 (0.1203) 0.2077 (0.0955) 0.1122 (0.0538)
p013 0.05 0.1177 (0.0516) 0.0730 (0.0255) 0.0547 (0.0236)
p021 0.20 0.3099 (0.1107) 0.3421 (0.0844) 0.2464 (0.0973)
p023 0.20 0.2906 (0.1103) 0.2706 (0.0973) 0.2702 (0.1054)
p031 0.10 0.1374 (0.0575) 0.1224 (0.0424) 0.1048 (0.0427)
p032 0.10 0.1980 (0.0924) 0.1539 (0.0602) 0.1550 (0.0641)
p112 0.10 0.2037 (0.0919) 0.1662 (0.0817) 0.0917 (0.0399)
p113 0.05 0.1022 (0.0444) 0.0644 (0.0195) 0.0526 (0.0143)
p121 0.20 0.2614 (0.0980) 0.3380 (0.0795) 0.2267 (0.0695)
p123 0.20 0.2348 (0.0851) 0.2469 (0.0774) 0.2302 (0.0574)
p131 0.10 0.1539 (0.0616) 0.1528 (0.0536) 0.1260 (0.0373)
p132 0.30 0.3160 (0.0805) 0.2844 (0.0798) 0.3088 (0.0604)
τ11 -3.00 -3.5384 (0.5381) - -2.9805 (0.2382)
τ12 2.00 1.9934 (0.4420) - 1.9324 (0.2245)
τ13 1.50 1.5799 (0.1357) - 1.5371 (0.0998)
τ21 1.20 - 1.2775 (0.0267) 1.2345 (0.0278)
τ22 0.50 - 0.3812 (0.1350) 0.4578 (0.0927)
τ23 0.80 - 0.7673 (0.1096) 0.7568 (0.0834)
Σ11 2.00 2.5681 (0.4148) - 2.0325 (0.3065)
Σ12 0.20 - - 0.2048 (0.0497)
Σ22 0.10 - 0.1177 (0.0128) 0.1034 (0.0116)
1
σ2ε
10.00 - 8.4617 (0.4531) 8.4754 (0.4269)
Each value is the average posterior mean (average posterior standard deviation) of the
simulated sample. where πk is the initial probability of hidden state k, p
s
jk is the j, k
transition probability for the sth treatment group for the hidden states, τrk is the intercept
term for response r and hidden state k, Σ is the covariance matrix of the random effects,
and σ2ε is the residual error associated with response 2.
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probabilities, while the other modeled sources of heterogeneity (Σ11, Σ22 and σ
2
ε ) have all
increased. With the exception of a few of the placebo transition probabilities (e.g., p023




bias in the bivariate MHMM is relatively small, and is reassuring, that even when the
data are contaminated by some unmodeled process, the resulting estimates are generally
well-behaved.
Lastly, we present some results pertaining to hidden state classification from the two
simulation situations for each of the univariate and bivariate models in Table 4.5. The
results are generally what one would expect, with the bivariate models generally producing
better hidden state classification results than the univariate models. Further, classifica-
tion was more efficient in the situation without the contaminated data, but still performed
remarkably well in spite of this. In general, classification of observations in the intermedi-
ate state (hidden state 2) was most difficult, irrespective of model or contamination. We
additionally stratified the analysis of situation (2) on whether the observation was con-
taminated. In the non-contaminated observations, we found that the results were slightly
better than the overall AUC assessments. In the contaminated observations, we found
that the φ̂it2 is generally a poor predictor for hidden state two as measured by AUC in
all analyses. Surprisingly, the bivariate model does slightly worse than the univariate
CO model, but this is primarily caused by the fact that the bivariate analysis is ’doubly’
contaminated by both responses, but the univariate models are conducted in the subset
of observations which is contaminated in either of the responses, including the one it is
not considering. When we further restrict the analysis to those observations which are
contaminated within their respective responses, and remove from this analysis those that
are contaminated in the other response, the mean AUC2 C reduces to 0.3986 and 0.4626





































































































































































































































































































































































































































































































































































































































Overall, in this chapter we examined the potential utility of using a multivariate approach
to modeling data arising from data where heterogeneity in the responses can be attributed
to between-subject differences and to transition between disease states. We focused on
two areas of concern. The first pertains to the appropriateness of a MHMM multivariate
modeling approach to model data from settings such as a smoking cessation clinical trial.
The second concern is related to suitability of conducting inference about the hidden states,
and whether such inferences are meaningful. Overall, we find that use of a multivariate
model has several advantages over the use of separate univariate models under the same
MHMM framework. Further, we discover that both the locally decoded hidden state
probabilities (φ̂itk), along with most probable hidden state (δ̂it) closely correspond with
the study-defined disease state definitions, and illustrate possible deficiencies for these
definitions.
Although we described in detail in Chapter 3 a modeling framework for multivariate
longitudinal response data under MHMM, it was not clear what benefits such an approach
would have over univariate or other modeling approaches. As we saw in section 4.3 there
are some clear benefits of this approach to modeling data such as those generated from our
motivating smoking cessation example. When comparing the model estimates generated
from the univariate SR and bivariate MHMMs, the hidden states in the bivariate case
clearly have more meaning, when compared to the univariate SR MHMM, which models
most of the heterogeneity in the SR response as being attributable to between-subject
differences. This result is generally observed in the simulation results in section 4.6, where
we often observe bias in the placebo group’s probability transition matrix, P (0), and hid-
den state dependent intercepts, τ . We think this partly due to the limited number of
observation times available for each patient, but note that the bivariate model’s estimates
are generally significantly less biased than either of the SR or CO univariate response
models. Lastly, under a multivariate MHMM there are some significant improvements
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of the posterior distribution of the random effects, which are severely skewed in the uni-
variate SR case, but is much less so under a multivariate approach. The asymmetry we
observe in the SR response random effect, is primarily caused by a very homogeneous
set of observations from patients self-reporting complete abstinence throughout the en-
tire six-week study period. We believe that if the study were continued for a while longer,
some of these subjects would relapse, and this would reduce some of the asymmetry noted.
Alternatively, other non-Gaussian or mixture model approaches could be used, but also
have limitations. Non-parametric approaches have been used to model the random effects
in univariate MHMMs (Maruotti and Ryden, 2009), but have been generally limited to
univariate random effects. Under our current approach of separate but correlated random
effects, this may prove more difficult. The second approach involving mixture models may
be more promising, but one would likely want to consider the possibility that the mixtures
were dependent on the hidden states we have been modeling. With the limited sample size
in this dataset, we believe this would also be difficult, especially considering we believe the
random effect distribution asymmetry is caused by primarily a very homogeneous set of
observations to begin with. The results in section 4.3 along with the simulation results of
section 4.6 demonstrate the advantages of using a multivariate model over the component
univariate models.
The second concern pertains to hidden state inference. In general, the modeling frame-
work we have outlined in Chapters 3 and 4 is going to describe the heterogeneity in the
response under the model assumptions. The hidden states need not describe any specific
disease or other discrete states, but in general, both the plausibility and utility of the mod-
eling approach will be improved greatly if they have some kind of interpretation. Often,
as was the case in the motivating smoking cessation clinical trial, study disease states will
be defined by these longitudinal responses, instead of being viewed as the disease states
generating the longitudinal response, which would ideally be more appropriate. In a case
such as this, there is no gold standard as to which to calibrate the hidden states to, as
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the corresponding longitudinal response used to define the study’s disease states are prone
to error. With that said, a general agreement between the hidden states and the study-
defined disease states would be ideal. We do see such an agreement, with very high areas
under the ROC curve, and a generally high overall agreement, when including or excluding
the intermediate second hidden state which is not study-defined. When we look at cases
of disagreement, we see situations which may be illustrative to inform further work to
improve our model, or provide guidance to conduct future smoking cessation studies. For
the most part, the MHMM approach is more sensitive to relative changes in CO levels
within a subject, and less sensitive to small isolated cases of SR smoking (most often a
single cigarette in a week) when contrasted with the study-defined definitions which are
very strict about any SR smoking, and do not consider relative changes in CO levels, with
only absolute values exceeding the threshold defining smoking. The differences may illus-
trate future work that can be done to improve modeling approaches, by modeling directly
a stricter definition of SR smoking by explicitly defining hidden state one as having a SR
rate of 0. Alternatively, this may also provide some guidance for future studies which may
improve study-defined disease outcomes which use relative changes in CO, or less stringent
definitions of SR smoking, when isolated or small relapses occur.
With that said, the agreement of the hidden states done by either δ̂it or φ̂itk and the
study-defined disease states is quite high. This is quite impressive given that this modeling
approach was largely an unsupervised task, where the data were used to generate the
hidden states, without any explicit labelling of observations. Further, we have been able
to model more effectively an intermediate state which has been hypothesized to exist for
subjects attempting to cease smoking, and may be important in describing a treatment
effect. While other methods have been developed to explain heterogeneity in a longitudinal
response, these approaches have generally used approaches which classify entire trajectories
on one response or several responses of the same type into static groups (e.g., Lin et al.
(2000)). In many settings static groups will be appropriate, but in other settings such as
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smoking cessation, it seems unlikely that this approach would work well. Moreover, in the
general setting, these approaches have been further limited by their ability to use responses
of different data types, such as the discrete and continuous data we have encountered
throughout Chapters 3 and 4.
Overall, we believe the multivariate longitudinal data modeling framework developed
in Chapter 3 provides a good basis to conduct inference, where the hidden states closely
correspond to well understood disease states. Using a multivariate MHMM over the uni-




Using MHMMs for Prediction and
other Missing Data Issues
5.1 Background
In Chapter 3 we described a modeling framework which could describe heterogeneity in
multivariate longitudinal response data from between-subject differences in addition to a
dynamic hidden process. In Chapter 4, we assessed the utility of inference drawn from the
hidden states from these models to describe measurable clinical outcomes, and identified
several areas where the models may provide more insightful inference about the true clinical
outcome of interest instead of the measurable one. However, thus far we have largely
ignored two important issues encountered frequently in longitudinal data analysis. The
first issue we will examine will focus on the prediction of hidden states. The second topic
is somewhat related, and is related to justification and implementation of a method to
account for patient dropout in such studies. We will examine both of the issues in the
context of the same motivating clinical trial discussed throughout the previous chapters.
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5.2 Prediction of Hidden States
5.2.1 Methods
In Chapter 4, we described one way to conduct inference about the hidden states under a
MHMM, by using the locally decoded probabilities,







it = k) , (5.1)
where, Zit is the hidden state for subject i = 1, . . . , N , at time t = 1, . . . , ni, yi is the
complete set of R longitudinal responses for subject i over all t, bi is a vector of random
effects for subject i, Θ comprises all population-level parameters of the MHMM, and J are
the total number of samples generated from the MCMC algorithm described in Chapters
3 and 4.
Prediction of the hidden states in the future can take several forms, but will gener-
ally be some function of the current hidden states (or their decoded probabilities) and
the probability transition matrix for the hidden Markov process, P . For example, one
estimator for P (Zi,t+h = k|yi, bi,Θ) based on the MCMC output would be,











lk is the (l, k)
th entry of P h for the jth MCMC sample. If t + h ≤ ni, and the
data are complete, then one is conditioning on yi,t+h, and the situation is not of much
direct interest, as inference would be more efficiently conducted through φ̂itk. If t+h > ni,
then a more interesting situation would occur and could be utilized when one was trying to
predict post-follow-up hidden state distributions, or impute hidden states from data which
was missing resulting from study dropout. To illustrate this directly, we will evaluate ω̂itk
as a predictor for the the study-defined smoking definition of study visit t+ 1.
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5.2.2 Results
As mentioned previously, using ω̂itk to predict hidden states at time points which are
conditioned on is not so interesting in most situations. In order to evaluate ω̂itk for time
points in the future, we will fit the bivariate MHMM model discussed in Chapter 4 to a
subset of the data considered in those models. In this analysis, we will run the model
fitting procedure by MCMC restricting the observation times to only the first five weeks,
instead of six. This analysis is presented in Table 5.1 alongside the estimates provided in
Table 4.1 from Chapter 4.
In general, the subset analysis involving a maximum of five observation times, has sim-
ilar estimates to those provided in the previously performed analysis involving all six study
visits. In Table 5.1 we obtain what we would expect, that in general the analysis based on
only five time points generally has larger posterior standard deviation, representing more
uncertainty with less data.
We then use the subset model involving only five observation times, to predict the
hidden states in study visit six in the 250 subjects with the available data to perform
these analyses. Likewise to illustrate the differences, we also present the complete data (all
six observation times) analysis, which we would expect to have slightly higher predictive
power, based on the fact that one is conditioning on the observation one is trying to in
essence base prediction on.
As seen in Figure 5.1-5.2, the predictive value of ω̂i6k when conditioned on the longi-
tudinal response at t = 6 is higher than that of the subset analysis which only includes
the first five observation times. Overall, the ability to do prediction when no information
is known about future observations, is still quite good, with both AUCs for ω̂i61 and ω̂i63
exceeding 0.9.
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Max(ni) = 5 Subset
π1 0.7130 (0.0297) 0.7228 (0.0314)
π2 0.2146 (0.0289) 0.1932 (0.0304)
p012 0.0442 (0.0174) 0.0511 (0.0214)
p013 0.0136 (0.0077) 0.0182 (0.0102)
p021 0.2072 (0.0719) 0.1888 (0.0783)
p023 0.1745 (0.0598) 0.2129 (0.0746)
p031 0.1241 (0.0786) 0.2201 (0.1159)
p032 0.0877 (0.0796) 0.1973 (0.1356)
p112 0.0349 (0.0084) 0.0348 (0.0096)
p113 0.0083 (0.0037) 0.0119 (0.0050)
p121 0.2515 (0.0486) 0.2688 (0.0550)
p123 0.2271 (0.0437) 0.2124 (0.0484)
p131 0.0650 (0.0307) 0.0900 (0.0409)
p132 0.2007 (0.0501) 0.2429 (0.0640)
τ11 -5.2899 (0.2120) -5.1700 (0.2257)
τ12 4.4679 (0.2035) 4.4182 (0.2017)
τ13 1.3101 (0.0434) 1.2419 (0.0447)
τ21 1.1851 (0.0221) 1.1895 (0.0227)
τ22 0.2959 (0.0474) 0.2816 (0.0529)
τ23 0.8782 (0.0569) 0.8216 (0.0529)
Σ11 2.3318 (0.4179) 2.2239 (0.4090)
Σ12 0.1242 (0.0459) 0.1258 (0.0463)
Σ22 0.1048 (0.0111) 0.1023 (0.0113)
1
σ2ε
8.6795 (0.3676) 8.7250 (0.4158)
Each value is the posterior mean (posterior standard deviation). where πk is the initial
probability of hidden state k, psjk is the j, k transition probability for the s
th treatment
group for the hidden states, τrk is the intercept term for response r and hidden state k, Σ
is the covariance matrix of the random effects, and σ2ε is the residual error associated with
response 2.
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Figure 5.1: ROC curves for ω̂i61 and ω̂i63 in the complete data analysis
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Figure 5.2: ROC curves for ω̂i61 and ω̂i63 in the five observation time subset analysis
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5.3 Missing Data Issues
As mentioned in section 5.1, the motivating smoking cessation study had a somewhat
significant number of subjects who were enrolled in the study who dropped out before the
end of the six week treatment period. In Figure 5.3 we present the patient disposition
for the study, where 385 subjects were randomized to receive placebo or one of three
active treatments. Of these 385, 31 had no evaluable post-treatment initiation data, or
data which contained only one part of the bivariate response we were considering for the
MHMM models. This would occur when the patient submitted their first week’s SR data
(or part thereof), or had their CO measurements taken at the first post-treatment visit,
but did not complete the other component. While this information may be useful in some
contexts, in both of these cases, we have excluded these patients from analysis in Chapters
3-5, because the data was very limited to draw inference from if it existed at all. The
patients may play an important role in the study of smoking cessation treatment, but they
generally will not be able to help us conduct inference in the models we are considering.
Of the remaining 354 subjects we have considered in Chapters 3-5, we had 250 subjects
with complete data. Of the 104 subjects who did not have complete data, 50 had one or
more intermittently missing data. In many instances, these data were recorded as missing
due to a technical or other problem, and we therefore believe the mechanism by which
they are missing is largely ignorable. Not including the 31 subjects who dropped out near
or at week one with no evaluable data, we had an additional 54 subjects who made it
through just 37 days or fewer of the 42-day (6-week) treatment period.
While the problems with missing data extend to the intermittently missing data, we will
primarily focus on those 54 subjects who dropped out prior to the end of the study. In those
subjects, who had intermittent data, as others point out (Altman, 2007), under a missing
at random (MAR) assumption, the only modification that needs to be made to the methods
described in Chapters 3 and 4 is to how the hidden states (Z) are sampled. If observations
are missing between times t and t
′



















Figure 5.3: Patient disposition for the smoking cessation study
become, αit = αi,t′P
hG(yit) where, h = t − t
′
, and P h is the h−step transition matrix,
and G(yit) is as defined in Chapter 3. Similarly, the stochastic recursion used to update
the hidden states can be modified in a similar fashion. There is sufficient reason to believe
that the intermittently missing data are missing at random, as very often the missingness
was recorded being due to some technical error, or other external issue unrelated to the
subject’s responses. On the other hand, the missing data mechanism for those subjects
which dropped out, is less clear, and will be focus of further analysis.
Often subjects who drop out are assumed to be smokers, and analyses proceed under
this assumption, even when for instance, evidence of long term abstinence at 3 or 6 months
is obtained. Others (Borrelli et al., 2002) have cited concerns that those individuals who
drop out may be different in a number of ways when compared to either smokers or non-
smokers. One way of assessing these hypotheses, would be to examine the distributions
of φ̂itk for each k at the time of dropout. If the distributions of φ̂itk stratified by those
who completed the study, and those who dropped-out differed in many respects, then
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this may provide some evidence that the subjects who dropped out were a distinguishable
group, and the dropout mechanism is not ignorable. If however, the distributions of φ̂itk
were approximately similar to each other, then this would provide some evidence that
conditional on Zit at the time of dropout, the dropout mechanism may be ignorable. In
Figures 5.4-5.6, we plot histograms of φ̂itk in all observations (overall), in all observations
at t = 6, and in those observations at the time of dropout.
In Figures 5.4-5.6 we note a common ”U”-shaped curve throughout, with most of the
values of φ̂itk being at [0, 1] interval boundaries. While there are a relatively higher number
of observations with φ̂itk values between 0.1 and 0.9 for k = 1 or 2, the sample sizes are
relatively small, and it is difficult to attribute these. While the shapes of these distributions
are generally the same, this does not mean that the hidden state distributions are identical
for each of the groups considered. For instance, for the t = 6 observations, the mean values
of φ̂itk are 0.787, 0.0767, and 0.136 for k = 1, 2, and 3, respectively. At the dropout time,
the mean value of φ̂itk is 0.574, 0.214 and 0.212 for k = 1, 2, and 3, respectively.
In addition to the discussion related to the hidden states at the time of dropout,
there may be additional justification for a MAR assumption for the subjects who dropped
out. In an unpublished analysis (Dubin, 2012), subjects with low adherence to therapy in
the previous week, or with moderate to severe adverse events were found more likely to
dropout. While some of the adverse events may be due to the treatment, many are related
to withdrawal symptoms or craving, and many of these may be modeled effectively by the
hidden states. This along with the analysis of the distributions of φ̂itk may make a MAR
assumption reasonably plausible. Further justification or exploration of the missing data
mechanism is probably merited, and should be undertaken in this and other datasets.
5.3.1 Methods
Under an ignorable missing data mechanism, we can modify the methodologies we have
described previously in Chapters 3 and 4. Without loss of generality, but primarily be-
112
All Observations


























































































































Figure 5.6: Histogram of the distribution of φ̂it3 = P (Zit = 3|yi, bi,Θ) overall, at t = 6
and at dropout.
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cause our focus is on those subjects who drop out of the study, assume that there are no
intermittently missing data, and the missing data are only generated from those subjects
who drop out of the study. Let yOBSi be the observed data for the multivariate longitudinal
response for subject i observed up to time ni, and let y
MISS
i be the missing data for the




i ] are both
combined, and refer to the complete longitudinal response data. Similarly, for the same
common data points as the longitudinal response, let zOBSi be the hidden states for all
observations for t = 1, . . . , ni, and let z
MISS
i be the missing data for the hidden states




i ] are both combined, and refer to the complete
hidden state data. Assume, that V > ni for all i, where V is the maximum follow-up for
all subjects.
Ideally, we would like to sample from [Θ, bi|yC ], and conduct our inference from the
posterior conditional on the complete data. Since we do not have access to the completed
data, we can impute the missing data to complete it, and approximate sampling from this
posterior. To do this, we add to the approach described in Chapters 3 and 4 to sample from
[zMISS|zOBS, ...] and [yMISS|yOBS, ...]. This is relatively straightforward if the missing
data mechanism is ignorable, and is based on the conditional independence assumptions
contained in the modeling framework. At each iteration, [zOBSi |yOBSi ,Θ, bi] is sampled
as described in section 3.3.2 using the observed longitudinal response data only. We note
that, [zMISSi |zOBSi ,yOBSi ,Θ, bi] = [zMISSi |zOBSi ,P ], and Zit′ (ni < t
′ ≤ V ) can be sampled
from P (Zit′ = k|Zi,t′−1 = j) = p
(s)
jk , the (j, k)
th entry from the sth treatment group’s
transition matrix, and then iteratively for times t
′
+1, . . . , V , conditioning on the previous
sampled state. Once zMISSi has been sampled, we can sample from [y
MISS
i |yOBSi , zCi ,Θ, bi]
which can be done for each response independently, the components of yMISSi can be
sampled for time point t > ni such that Yirt|Zit = k ∼ frk(yirt|Θ), where frk(.) is the
density or mass function for response r in hidden state k. At each iteration of sampling
from the posterior by Gibbs sampling, yMISS and zMISS can be generated to complete
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their respective datasets after which yC and zC can be used to sample from each of
the other full conditionals: [τ ,β|yC , b, zC ], [P |zC ], [π|zC ], [Σ|b], [ 1
σ2ε
|yC ,β, τ , b, zC ] and
[b|yC ,β, τ , b, zC ,σ2ε ].
We used this methodology to impute the missing data for each of the binomial and
Poisson count models considered in Chapter 3 and 4, respectively. Those results will then
be compared to the complete case and the available data analyses.
5.3.2 Results
As one can seen in Tables 5.2 and 5.3, the results from the complete case, available data
and imputed missing data do not differ substantially, in either models based on the SR
count by a binomial (number of days) model, or a Poisson (cigarette count) model. As
would be expected, the complete case analysis generally has the highest posterior standard
deviation, given it has the smallest number of observations and subjects used. In general,
the imputed missing data analysis has a slightly higher posterior standard deviation in
most parameter estimates, representing increased uncertainty due to the missing data.
5.4 Discussion
Overall, we have seen that prediction of the hidden states can be done in a similar fashion
to how classification of hidden states was done in Chapter 4. Prediction based on estima-
tors such as ω̂itk is relatively effective in discriminating between future smoking and non-
smoking observations as determined by the study-definition, at least for the subsequent
week. Further analysis of properties of ω̂itk to assess its prediction over longer periods
of time, is an area of future investigation. Generalizing these predictions of longer-term
abstinence may be possible, but we believe it to be much more difficult, as the transition
probability matrix and perhaps even the Markov assumption may not be be sustained after
the observation/treatment period of six weeks is completed. To illustrate this, the sta-
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Table 5.2: Bivariate MHMM results for three different missing data scenarios under the








π1 0.7662 (0.0459) 0.7569 (0.0408) 0.7495 (0.0422)
π2 0.1862 (0.0439) 0.1787 (0.0386) 0.1829 (0.0405)
p012 0.0273 (0.0168) 0.0234 (0.0140) 0.0236 (0.0143)
p013 0.0099 (0.0069) 0.0124 (0.0074) 0.0132 (0.0078)
p021 0.3734 (0.1191) 0.2799 (0.0978) 0.2506 (0.0917)
p023 0.1714 (0.0821) 0.1881 (0.0763) 0.1847 (0.0768)
p031 0.0691 (0.0631) 0.0661 (0.0605) 0.0601 (0.0559)
p032 0.2983 (0.1175) 0.3076 (0.1180) 0.3016 (0.1167)
p112 0.0413 (0.0120) 0.0421 (0.0114) 0.0425 (0.0113)
p113 0.0033 (0.0031) 0.0045 (0.0033) 0.0048 (0.0035)
p121 0.2617 (0.0650) 0.2669 (0.0640) 0.2698 (0.0641)
p123 0.2210 (0.0626) 0.2041 (0.0581) 0.2108 (0.0592)
p131 0.0833 (0.0411) 0.0768 (0.0378) 0.0744 (0.0364)
p132 0.1180 (0.0630) 0.1158 (0.0606) 0.1235 (0.0598)
τ11 -5.5827 (0.3067) -5.3024 (0.2700) -5.3464 (0.2727)
τ12 3.8310 (0.3094) 3.9877 (0.2854) 3.9975 (0.2921)
τ13 2.1909 (0.3809) 2.1059 (0.3937) 1.9559 (0.4172)
τ21 1.1755 (0.0252) 1.1902 (0.0229) 1.1845 (0.0229)
τ22 0.2987 (0.0758) 0.3116 (0.0819) 0.3118 (0.0810)
τ23 1.0737 (0.0621) 1.1195 (0.0614) 1.1037 (0.0614)
Σ11 6.5650 (1.2101) 6.8945 (1.1307) 6.8228 (1.1296)
Σ12 0.3108 (0.0842) 0.3311 (0.0792) 0.3183 (0.0777)
Σ22 0.1059 (0.0128) 0.1011 (0.0112) 0.0986 (0.0110)
1
σ2ε
10.3074 (0.5051) 9.9166 (0.4831) 10.0166 (0.4944)
where πk is the initial probability of hidden state k, p
s
jk is the j, k transition probability for
the sth treatment group for the hidden states, τrk is the intercept term for response r and
hidden state k, Σ is the covariance matrix of the random effects, and σ2ε is the residual
error associated with response 2.
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Table 5.3: Bivariate MHMM results for three different missing data Scenarios under the








π1 0.7475 (0.0372) 0.7130 (0.0297) 0.7258 (0.0298)
π2 0.1892 (0.0368) 0.2146 (0.0289) 0.1969 (0.0286)
p012 0.0409 (0.0197) 0.0442 (0.0174) 0.0414 (0.0161)
p013 0.0106 (0.0072) 0.0136 (0.0077) 0.0126 (0.0073)
p021 0.2661 (0.0990) 0.2072 (0.0719) 0.2880 (0.0847)
p023 0.1564 (0.0689) 0.1745 (0.0598) 0.2488 (0.0747)
p031 0.1239 (0.0780) 0.1241 (0.0786) 0.1203 (0.0698)
p032 0.0721 (0.0698) 0.0877 (0.0796) 0.0849 (0.0737)
p112 0.0374 (0.0100) 0.0349 (0.0084) 0.0359 (0.0088)
p113 0.0089 (0.0044) 0.0083 (0.0037) 0.0085 (0.0039)
p121 0.2362 (0.0531) 0.2515 (0.0486) 0.2582 (0.0498)
p123 0.2361 (0.0479) 0.2271 (0.0437) 0.2348 (0.0445)
p131 0.0786 (0.0344) 0.0650 (0.0307) 0.0643 (0.0299)
p132 0.1724 (0.0504) 0.2007 (0.0501) 0.1973 (0.0489)
τ11 -5.4652 (0.2731) -5.2899 (0.2120) -5.1772 (0.2132)
τ12 4.2017 (0.2915) 4.4679 (0.2035) 4.3274 (0.2214)
τ13 1.3120 (0.0632) 1.3101 (0.0434) 1.3068 (0.0441)
τ21 1.1671 (0.0248) 1.1851 (0.0221) 1.1876 (0.0222)
τ22 0.2708 (0.0526) 0.2959 (0.0474) 0.2801 (0.0469)
τ23 0.8727 (0.0575) 0.8782 (0.0569) 0.8791 (0.0526)
Σ11 2.7983 (0.6228) 2.3318 (0.4179) 2.5771 (0.4644)
Σ12 0.1102 (0.0539) 0.1242 (0.0459) 0.1399 (0.0453)
Σ22 0.1036 (0.0117) 0.1048 (0.0111) 0.1052 (0.0109)
1
σ2ε
9.3642 (0.4317) 8.6795 (0.3676) 8.7176 (0.3707)
where πk is the initial probability of hidden state k, p
s
jk is the j, k transition probability for
the sth treatment group for the hidden states, τrk is the intercept term for response r and
hidden state k, Σ is the covariance matrix of the random effects, and σ2ε is the residual
error associated with response 2.
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tionary distribution based on estimates of P in either treatment group would be roughly
[0.7, 0.1, 0.2], where typically the longterm abstinence rates are much less (about 20%),
though, admittedly, this is really comparing apples to oranges, as often in the initial study
period the participants are on assigned treatment, whereas in post-treatment follow-up
the participants are typically off treatment.. Some caution is therefore warranted before
attempting to generalize these results to long-term smoking status.
In section 5.3 we discussed missing data issues, and examined the hypothesis put forth
by Borrelli et al. (2002) that subjects who drop out of smoking cessation intervention
studies are distinct from individuals who are classified as smokers or non-smokers in such
studies. An alternative hypothesis could be that the distinct population Borrelli et al.
(2002) observed was actually a mixture of diseases states. We believe we have provided
some evidence for this latter alternative hypothesis. In general, we see that subjects,
regardless of the time at which we observe them, have generally a high propensity to be in
one of the three hidden disease states used in our analyses. Rarely do individuals have a
mixed propensity to be classified in multiple hidden disease states. This observation seems
to generalize to individuals at the time of dropout, and we therefore believe that those
who drop out are actually a mixture of all three hidden states at the time of dropping out.
We would estimate the proportions of this mixture to be about 0.574, 0.214 and 0.212,
which represents a significantly higher prevalence of hidden state two and three than
would be observed in subjects who did not dropout. We believe that this may explain the
observation by Borrelli et al. (2002) about subjects who drop out. We also point out that
a common practice which assumes that subjects who drop out of smoking cessation studies
as smokers is likely not entirely appropriate. In general, we note that those who drop out
are more likely to not be in hidden state one which generally identifies with abstainers, but
at the time of dropout, we generally observe more abstainers than non-abstainers, which
calls into question the legitimacy of this assumption.
Lastly, we examined how to incorporate the additional uncertainty caused by the miss-
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ing data. We suggest an imputation approach which assumes ignorability of the missing
data mechanism, which we believe to be appropriate, since information about the current
disease state seems to be very predictive of future disease states, and this information
seems to generalize to both subjects who dropped out and those who did not in a similar
fashion. This is only one way of conducting analysis to address missing data issues. Other
imputation (e.g., Liu, Taylor and Belin (2000)) and other approaches (e.g., Ibrahim, Chen
and Lipsitz (2001)) could also be used under a MHMM to account for missing data, with
careful attention paid to both the observed and hidden components of the MHMM frame-
work. Implementation and comparisons of different modelling approaches is an area of
future work.
We believe MHMMs provide a unique opportunity to conduct inference as it relates to
prediction of hidden states, and also address issues related to missing data. As we have
shown, this approach provides a good framework for evaluating issues such as ignorability
of the missing data mechanism, and other hypotheses related to subjects who drop out.
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Chapter 6
Mixed Effects Hidden Markov
Models for Multivariate Longitudinal
Data: Summary and Future Work
6.1 Summary
6.1.1 Modelling Framework
In Chapter 3, we described a modeling framework to describe multivariate longitudinal
data, where heterogeneity within the response can be described by between-subject dif-
ferences, in addition to heterogeneity caused by dynamic changes to an underlying hidden
disease state. We restricted our consideration of dynamic models for the hidden disease
states transitions to M -state first-order discrete time Markov models. We believe that this
class of models will describe many situations well, including the study design we considered
– a randomized clinical trial for the study of the treatment of addiction.
The modeling framework built upon the work of others (e.g., Altman (2007); Gue-
orguieva and Agresti (2001)) in both the univariate longitudinal response literature for
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hidden Markov models, and the multivariate longitudinal data literature, where utilizing
separate, but correlated random effects between responses has been used in several set-
tings. As we have shown, computation can be done by maximizing the marginal likelihood,
after integrating over the random effects distribution, but in most situations the computa-
tional burden of fitting such models will be extensive. Under this approach computation
time significantly increases as a function of overall sample size, hidden state space size,
and most importantly the number of responses being considered. In general, it is possible
to fit such models by maximum likelihood estimation with a moderately sized sample, but
for large hidden state spaces or responses with dimension greater than two, the computa-
tion time is significant. Since both of these latter scenarios involving more responses or a
larger hidden state space are common issues one will want to examine under this modeling
framework, we believe other methodologies will need to be utilized in the general setting.
Other approaches to modeling MHMMs, including semi-parametric approaches (Maruotti
and Ryden, 2009) may be useful in univariate responses or for independent random effects
distributions, but with these limitations, they will not generally be applicable to most sit-
uations encountered modeling a multivariate longitudinal response under a MHMM. With
all this in mind, we chose to implement computation through a Bayesian approach using
Markov chain Monte Carlo. This approach is relatively straightforward to implement, and
can be extended quite easily to other more complex settings.
Under the various simulation studies in Chapter 3, this methodology generally per-
formed well, in terms of producing unbiased estimators for the model parameters, and
having approximately frequentist coverage on posterior intervals. In certain situations,
bias was noted in some of the parameter estimates, and was generally the result of a flat
posterior. This occurred mostly in components of the hidden state probability transition
matrix, and we attribute this mainly to the low expected number of transitions observed
in smaller strata (i.e., in our case the placebo group which had 1/3 the number of sub-
jects as those on active treatment). The occurrence of a flat prior and subsequent biased
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estimation can be caused by a number of different factors examined in Chapter 3, and is
something one needs to be aware of when fitting such models. This phenomena did not
occur in the full analysis of the smoking cessation dataset, we believe largely due to the
well-separated modes of the observed response conditional on the hidden response.
In Chapter 4, under different simulation scenarios, there appears to be a clear benefit
of modeling the data as a multivariate response. When compared to the two separate
univariate response models, a bivariate model which modeled both responses simultane-
ously was shown to be superior in many respects, but in particular, the amount of bias
observed in many of the parameters was significantly reduced. This would suggest that
adding a longitudinal response which has some of the heterogeneity explained by the same
underlying disease state to multivariate response MHMMs may improve inference drawn
from such a model.
While we have considered one example where a multivariate longitudinal response is
described by a MHMM, there may be other settings where this is applicable as well. In
general, in the study of substance abuse and addiction, it is common to monitor subjects
over time by self-reported use and biochemical confirmation (e.g., urinalysis), and this
would be another obvious application of our approach. Psychiatric diseases as well often
administer a battery of questionnaires to determine severity and presence of mental illness,
and often these diseases are believed to have multiple dynamic disease states. It may also
be the case, where only a univariate response is available for a particular disease area, and
although a MHMM would apply, no additional responses are available which are known to
describe the disease state. It is often the case that in many of these chronic illnesses, the
dynamic disease states severely affect quality of life in the individuals. In such a setting,
it would seem logical to model the univariate longitudinal response alongside the (possibly
multivariate) quality of life response under a MHMM for multivariate response framework
we describe in Chapter 3.
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6.1.2 Classification and Prediction of Disease States in Smoking
Cessation
In Chapter 4, we examined how well the hidden states describe already utilized disease state
definitions in a smoking cessation clinical trial. We generally relied on estimates from the
locally decoded probabilities of the hidden states. These study-defined disease states are
typically characterized by thresholds of one or more longitudinal responses. While far from
a ’gold-standard’, it would be desirable that the hidden states we model throughout this
thesis roughly correspond to these known definitions, and when discrepancies do occur,
they illustrate differences between the hidden and study-defined disease states. This is
generally the case, where we see a high correspondence between the hidden states and
those defined in the study protocol. Discrepancies typically occur when the MHMM model
detects relative increases in CO-levels as evidence of non-smoking, whereas the study
defined thresholds only consider absolute levels of CO. Similarly, the MHMM hidden states
are generally forgiving for isolated self-reported smoking observation (usually fewer than
7 cigarettes in a week), when not accompanied by an increase in CO-levels, or sustained
SR counts through subsequent weeks.
We believe these discrepancies describe two areas where one may want to improve the
study definitions, or alternatively, enforce stricter adherence to abstinence in the lowest
hidden state within the model approach itself. The close agreement between these two
estimates of disease state, is reassuring, and generally leads one to believe that a MHMM
is useful in the setting of smoking cessation intervention studies. The MHMM approach
also has the additional benefit of modeling the intermediate second hidden state, believed
to describe withdrawal. This state is much more difficult for study investigators to define
and measure, but may play an important role in assisting people in quitting smoking
(Killeen, 2011).
In Chapter 5, we showed how prediction of hidden states can be done similarly to the
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classification of the hidden states. In general, prediction of future hidden states can be
done relatively efficiently, and sampling the hidden states will play an important role in
imputation approaches to addressing the issue of missing data.
6.1.3 Missing Data Issues
Missing data as a whole, but in particular study dropout is a problem frequently en-
countered in longitudinal data analysis, and we encounter it when analysing the dataset
from our motivating example. A MHMM approach allows for a unique opportunity to
test for non-ignorability of the dropout mechanism, by examining the distribution of the
locally decoded probabilities of the hidden states at different time points, including the
time leading up to the study dropouts. This along with other information was used as
a justification for a missing at random (MAR) assumption, which we used to describe a
methodology to impute the missing data (both the observed longitudinal data in addition
to the hidden states) during the analysis procedure. While future work may be required
to further provide justification for the MAR assumption in our setting, the approach we
described could be adapted to whenever such an assumption was appropriate.
6.2 Future Work
We believe that future work falls into three categories. The first obvious area of work
would be to apply and extend the modeling framework to other settings and situations.
The second topic is related to model selection and hypothesis testing, and is an important
topic we have largely ignored. Lastly, we have outlined a very basic procedure for imputing




We have outlined a framework for modeling multivariate longitudinal data as a MHMM,
but have generally limited our analysis to a bivariate response. In practice, as mentioned
in section 6.1.1, multivariate longitudinal data can consist of many more responses. While
we did observe some definite benefits of analyzing a bivariate response over two univariate
responses under a MHMM, it remains unclear if these benefits will extend to further
dimensions of responses, or other situations. Increasing the dimension of the longitudinal
response will also increase the computational complexity of the MCMC procedure, and it
remains to be seen if the current modeling approach is feasible computationally for large
response numbers. Improvements to sampling approaches may be necessary to accomplish
this, or further modeling assumptions, for instance, pertaining to the variance components
of the random effects, may be required.
Altman (2007) has proposed further extensions for univariate longitudinal response
MHMMs to allow for between-subject heterogeneity of the hidden response also modeled
through random effects. Scott, James and Sugar (2005) proposes a Bayesian hierarchical
approach for describing heterogeneity in the hidden process, that could be adapted to the
modeling framework we have described. We believe these are important generalizations
that allow for increased flexibility in the modeling approach, but were unable to consider it
for our application due to the limited observation time (ni ≤ 6) available for each subject.
Use of such a modeling approach is increasingly difficult as the hidden state space increases,
and large observation time would be required, as a model which allows for heterogeneity
in all transition probabilities would require an additional M(M − 1) random effects in
addition to any random effects used in the observed part of the model.
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6.2.2 Model Selection
Throughout Chapters 3-5, we generally neglected any direct quantitative comparison of
models, largely due to our limited ability to do model selection and hypothesis testing.
Others (Celeux et al., 2006) have noted that using information criteria such as the de-
viance information criteria (DIC) are difficult in models such as random effect or mixture
models. In the setting of a MHMM, the models considered are both a random effect and
mixture model. In addition to this problem, often such approaches will require extensive
computation, and may not be feasible in many settings. Including covariates in these mod-
els is of particular interest, as the choice to include certain covariates in the observed or
hidden components of the model is not always obvious. For the reasons we have outlined,
providing model selection methodology or clarification on how to use already established
methods is an area of future research.
6.2.3 Missing Data Approaches
We provided one approach to accommodate missing data via dropout in Chapter 5 based on
a missing at random assumption. While we believe this assumption to be appropriate for
the dataset we considered, in general a sensitivity analysis should be conducted to consider
other assumptions such as a missing not at random (MNAR) dropout. Future work could
include the consideration of such alternative modeling assumptions (e.g., Ibrahim, Chen
and Lipsitz (2001)), in addition to the sensitivity of the MAR assumption to intermittently
missing data which occurred throughout the study.
6.3 Conclusions
MHMMs have been applied to the analysis of univariate longitudinal data, but can be
extended to the setting of multivariate longitudinal data analysis, provided that conditional
independence assumptions are appropriate. We have taken a Bayesian approach to conduct
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inference, and we believe the approach we have outlined can be adapted and extended to
many other important situations. Future work will focus on these extensions, in addition
to appropriate methods to conduct model selection and addressing subject dropout in such
models.
MHMMs are another class of model which can be used to explain heterogeneity within
a longitudinal response which would largely be inappropriately accounted for by standard
methodologies used for the analysis of longitudinal data. In the setting where data are
generated from individuals transitioning through multiple disease states, we believe that
MHMMs are an important tool for understanding the natural history of the disease, and
identifying the role treatment plays in modifying the disease states.
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